GO:0000785 | chromatin | 18.87% (30/159) | 3.92 | 0.0 | 0.0 |
GO:0140513 | nuclear protein-containing complex | 27.04% (43/159) | 2.83 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 42.77% (68/159) | 1.79 | 0.0 | 0.0 |
GO:0010604 | positive regulation of macromolecule metabolic process | 35.22% (56/159) | 2.07 | 0.0 | 0.0 |
GO:0009893 | positive regulation of metabolic process | 37.11% (59/159) | 1.94 | 0.0 | 0.0 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 38.99% (62/159) | 1.86 | 0.0 | 0.0 |
GO:0010468 | regulation of gene expression | 42.14% (67/159) | 1.72 | 0.0 | 0.0 |
GO:0060255 | regulation of macromolecule metabolic process | 46.54% (74/159) | 1.56 | 0.0 | 0.0 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 32.7% (52/159) | 2.07 | 0.0 | 0.0 |
GO:0051252 | regulation of RNA metabolic process | 36.48% (58/159) | 1.88 | 0.0 | 0.0 |
GO:0031325 | positive regulation of cellular metabolic process | 33.33% (53/159) | 2.01 | 0.0 | 0.0 |
GO:0051171 | regulation of nitrogen compound metabolic process | 44.03% (70/159) | 1.6 | 0.0 | 0.0 |
GO:0080090 | regulation of primary metabolic process | 45.28% (72/159) | 1.54 | 0.0 | 0.0 |
GO:0048518 | positive regulation of biological process | 47.8% (76/159) | 1.47 | 0.0 | 0.0 |
GO:0006357 | regulation of transcription by RNA polymerase II | 22.64% (36/159) | 2.65 | 0.0 | 0.0 |
GO:0010556 | regulation of macromolecule biosynthetic process | 37.11% (59/159) | 1.8 | 0.0 | 0.0 |
GO:0031323 | regulation of cellular metabolic process | 45.91% (73/159) | 1.49 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 32.08% (51/159) | 1.96 | 0.0 | 0.0 |
GO:0048522 | positive regulation of cellular process | 41.51% (66/159) | 1.59 | 0.0 | 0.0 |
GO:0009892 | negative regulation of metabolic process | 31.45% (50/159) | 1.96 | 0.0 | 0.0 |
GO:0009889 | regulation of biosynthetic process | 39.62% (63/159) | 1.63 | 0.0 | 0.0 |
GO:0019222 | regulation of metabolic process | 49.06% (78/159) | 1.35 | 0.0 | 0.0 |
GO:0003682 | chromatin binding | 15.72% (25/159) | 3.23 | 0.0 | 0.0 |
GO:0050789 | regulation of biological process | 66.04% (105/159) | 0.98 | 0.0 | 0.0 |
GO:0031326 | regulation of cellular biosynthetic process | 38.36% (61/159) | 1.63 | 0.0 | 0.0 |
GO:0006974 | cellular response to DNA damage stimulus | 17.61% (28/159) | 2.89 | 0.0 | 0.0 |
GO:0010605 | negative regulation of macromolecule metabolic process | 28.3% (45/159) | 1.96 | 0.0 | 0.0 |
GO:0048523 | negative regulation of cellular process | 35.22% (56/159) | 1.65 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 40.25% (64/159) | 1.47 | 0.0 | 0.0 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 24.53% (39/159) | 2.1 | 0.0 | 0.0 |
GO:0006355 | regulation of DNA-templated transcription | 30.82% (49/159) | 1.78 | 0.0 | 0.0 |
GO:2001141 | regulation of RNA biosynthetic process | 30.82% (49/159) | 1.77 | 0.0 | 0.0 |
GO:1903506 | regulation of nucleic acid-templated transcription | 30.82% (49/159) | 1.77 | 0.0 | 0.0 |
GO:0048519 | negative regulation of biological process | 40.88% (65/159) | 1.41 | 0.0 | 0.0 |
GO:0016570 | histone modification | 13.21% (21/159) | 3.25 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 30.19% (48/159) | 1.77 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 30.19% (48/159) | 1.77 | 0.0 | 0.0 |
GO:0050794 | regulation of cellular process | 58.49% (93/159) | 1.0 | 0.0 | 0.0 |
GO:0065007 | biological regulation | 66.67% (106/159) | 0.86 | 0.0 | 0.0 |
GO:0031324 | negative regulation of cellular metabolic process | 24.53% (39/159) | 2.04 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 32.08% (51/159) | 1.67 | 0.0 | 0.0 |
GO:1902494 | catalytic complex | 22.01% (35/159) | 2.18 | 0.0 | 0.0 |
GO:0006996 | organelle organization | 27.67% (44/159) | 1.83 | 0.0 | 0.0 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 23.27% (37/159) | 2.07 | 0.0 | 0.0 |
GO:0051246 | regulation of protein metabolic process | 23.27% (37/159) | 2.07 | 0.0 | 0.0 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 13.21% (21/159) | 3.1 | 0.0 | 0.0 |
GO:0009894 | regulation of catabolic process | 16.35% (26/159) | 2.65 | 0.0 | 0.0 |
GO:0005654 | nucleoplasm | 20.75% (33/159) | 2.18 | 0.0 | 0.0 |
GO:0031328 | positive regulation of cellular biosynthetic process | 23.9% (38/159) | 1.93 | 0.0 | 0.0 |
GO:0009891 | positive regulation of biosynthetic process | 23.9% (38/159) | 1.91 | 0.0 | 0.0 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 23.27% (37/159) | 1.94 | 0.0 | 0.0 |
GO:0005515 | protein binding | 65.41% (104/159) | 0.79 | 0.0 | 0.0 |
GO:0031329 | regulation of cellular catabolic process | 13.84% (22/159) | 2.77 | 0.0 | 0.0 |
GO:0005694 | chromosome | 11.95% (19/159) | 3.04 | 0.0 | 0.0 |
GO:0016043 | cellular component organization | 38.99% (62/159) | 1.26 | 0.0 | 0.0 |
GO:0051128 | regulation of cellular component organization | 22.01% (35/159) | 1.92 | 0.0 | 0.0 |
GO:0071840 | cellular component organization or biogenesis | 40.25% (64/159) | 1.21 | 0.0 | 0.0 |
GO:0051254 | positive regulation of RNA metabolic process | 20.75% (33/159) | 1.98 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 27.04% (43/159) | 1.63 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 46.54% (74/159) | 1.06 | 0.0 | 0.0 |
GO:0008134 | transcription factor binding | 11.32% (18/159) | 2.99 | 0.0 | 0.0 |
GO:0070603 | SWI/SNF superfamily-type complex | 6.29% (10/159) | 4.48 | 0.0 | 0.0 |
GO:0051716 | cellular response to stimulus | 35.85% (57/159) | 1.28 | 0.0 | 0.0 |
GO:0051098 | regulation of binding | 8.81% (14/159) | 3.48 | 0.0 | 0.0 |
GO:0032502 | developmental process | 51.57% (82/159) | 0.93 | 0.0 | 0.0 |
GO:0016604 | nuclear body | 11.95% (19/159) | 2.78 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 33.96% (54/159) | 1.32 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 21.38% (34/159) | 1.84 | 0.0 | 0.0 |
GO:0022402 | cell cycle process | 16.98% (27/159) | 2.15 | 0.0 | 0.0 |
GO:0042393 | histone binding | 8.18% (13/159) | 3.59 | 0.0 | 0.0 |
GO:0030154 | cell differentiation | 18.87% (30/159) | 1.99 | 0.0 | 0.0 |
GO:0005667 | transcription regulator complex | 8.81% (14/159) | 3.38 | 0.0 | 0.0 |
GO:0048869 | cellular developmental process | 23.9% (38/159) | 1.68 | 0.0 | 0.0 |
GO:0003712 | transcription coregulator activity | 10.06% (16/159) | 3.07 | 0.0 | 0.0 |
GO:0006259 | DNA metabolic process | 14.47% (23/159) | 2.37 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 32.7% (52/159) | 1.31 | 0.0 | 0.0 |
GO:1904949 | ATPase complex | 6.29% (10/159) | 4.19 | 0.0 | 0.0 |
GO:0010564 | regulation of cell cycle process | 11.95% (19/159) | 2.65 | 0.0 | 0.0 |
GO:0045893 | positive regulation of DNA-templated transcription | 18.24% (29/159) | 1.95 | 0.0 | 0.0 |
GO:0051247 | positive regulation of protein metabolic process | 13.84% (22/159) | 2.35 | 0.0 | 0.0 |
GO:1903508 | positive regulation of nucleic acid-templated transcription | 18.24% (29/159) | 1.94 | 0.0 | 0.0 |
GO:1902680 | positive regulation of RNA biosynthetic process | 18.24% (29/159) | 1.94 | 0.0 | 0.0 |
GO:0050793 | regulation of developmental process | 28.93% (46/159) | 1.39 | 0.0 | 0.0 |
GO:0033554 | cellular response to stress | 26.42% (42/159) | 1.48 | 0.0 | 0.0 |
GO:0018205 | peptidyl-lysine modification | 9.43% (15/159) | 3.02 | 0.0 | 0.0 |
GO:0003677 | DNA binding | 24.53% (39/159) | 1.54 | 0.0 | 0.0 |
GO:0051641 | cellular localization | 20.13% (32/159) | 1.77 | 0.0 | 0.0 |
GO:0000792 | heterochromatin | 5.66% (9/159) | 4.27 | 0.0 | 0.0 |
GO:0048856 | anatomical structure development | 40.88% (65/159) | 1.04 | 0.0 | 0.0 |
GO:1903046 | meiotic cell cycle process | 10.69% (17/159) | 2.7 | 0.0 | 0.0 |
GO:0004386 | helicase activity | 7.55% (12/159) | 3.37 | 0.0 | 0.0 |
GO:0005488 | binding | 72.96% (116/159) | 0.54 | 0.0 | 0.0 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 11.95% (19/159) | 2.42 | 0.0 | 0.0 |
GO:1990234 | transferase complex | 13.21% (21/159) | 2.25 | 0.0 | 0.0 |
GO:0022414 | reproductive process | 37.11% (59/159) | 1.08 | 0.0 | 0.0 |
GO:0048583 | regulation of response to stimulus | 31.45% (50/159) | 1.21 | 0.0 | 0.0 |
GO:0000280 | nuclear division | 6.29% (10/159) | 3.73 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 45.91% (73/159) | 0.89 | 0.0 | 0.0 |
GO:0007610 | behavior | 8.18% (13/159) | 3.09 | 0.0 | 0.0 |
GO:0043414 | macromolecule methylation | 8.18% (13/159) | 3.09 | 0.0 | 0.0 |
GO:0140535 | intracellular protein-containing complex | 12.58% (20/159) | 2.28 | 0.0 | 0.0 |
GO:0018193 | peptidyl-amino acid modification | 12.58% (20/159) | 2.27 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 45.91% (73/159) | 0.88 | 0.0 | 0.0 |
GO:0051052 | regulation of DNA metabolic process | 9.43% (15/159) | 2.75 | 0.0 | 0.0 |
GO:0033043 | regulation of organelle organization | 11.95% (19/159) | 2.33 | 0.0 | 0.0 |
GO:0016573 | histone acetylation | 6.29% (10/159) | 3.58 | 0.0 | 0.0 |
GO:0006475 | internal protein amino acid acetylation | 6.29% (10/159) | 3.56 | 0.0 | 1e-06 |
GO:0018393 | internal peptidyl-lysine acetylation | 6.29% (10/159) | 3.56 | 0.0 | 1e-06 |
GO:0018394 | peptidyl-lysine acetylation | 6.29% (10/159) | 3.55 | 0.0 | 1e-06 |
GO:0006725 | cellular aromatic compound metabolic process | 32.7% (52/159) | 1.12 | 0.0 | 1e-06 |
GO:0006396 | RNA processing | 15.72% (25/159) | 1.86 | 0.0 | 1e-06 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 7.55% (12/159) | 3.08 | 0.0 | 1e-06 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 15.09% (24/159) | 1.91 | 0.0 | 1e-06 |
GO:0009890 | negative regulation of biosynthetic process | 15.72% (25/159) | 1.84 | 0.0 | 1e-06 |
GO:0031399 | regulation of protein modification process | 12.58% (20/159) | 2.14 | 0.0 | 1e-06 |
GO:0006473 | protein acetylation | 6.29% (10/159) | 3.45 | 0.0 | 1e-06 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 11.95% (19/159) | 2.2 | 0.0 | 1e-06 |
GO:1902531 | regulation of intracellular signal transduction | 11.95% (19/159) | 2.2 | 0.0 | 1e-06 |
GO:2000177 | regulation of neural precursor cell proliferation | 3.77% (6/159) | 4.97 | 0.0 | 1e-06 |
GO:0033044 | regulation of chromosome organization | 6.92% (11/159) | 3.18 | 0.0 | 1e-06 |
GO:0009896 | positive regulation of catabolic process | 8.81% (14/159) | 2.65 | 0.0 | 2e-06 |
GO:0010629 | negative regulation of gene expression | 11.32% (18/159) | 2.23 | 0.0 | 2e-06 |
GO:0010647 | positive regulation of cell communication | 12.58% (20/159) | 2.07 | 0.0 | 2e-06 |
GO:0032259 | methylation | 8.81% (14/159) | 2.63 | 0.0 | 2e-06 |
GO:0048285 | organelle fission | 6.29% (10/159) | 3.32 | 0.0 | 2e-06 |
GO:0009967 | positive regulation of signal transduction | 11.95% (19/159) | 2.13 | 0.0 | 2e-06 |
GO:0061780 | mitotic cohesin loading | 2.52% (4/159) | 6.48 | 0.0 | 2e-06 |
GO:0071921 | cohesin loading | 2.52% (4/159) | 6.48 | 0.0 | 2e-06 |
GO:0006281 | DNA repair | 9.43% (15/159) | 2.49 | 0.0 | 2e-06 |
GO:0009966 | regulation of signal transduction | 20.13% (32/159) | 1.48 | 0.0 | 3e-06 |
GO:0042766 | obsolete nucleosome mobilization | 3.14% (5/159) | 5.41 | 0.0 | 3e-06 |
GO:0051099 | positive regulation of binding | 5.03% (8/159) | 3.81 | 0.0 | 3e-06 |
GO:0003723 | RNA binding | 18.87% (30/159) | 1.54 | 0.0 | 3e-06 |
GO:0051726 | regulation of cell cycle | 11.95% (19/159) | 2.09 | 0.0 | 3e-06 |
GO:1902275 | regulation of chromatin organization | 4.4% (7/159) | 4.18 | 0.0 | 3e-06 |
GO:0040029 | epigenetic regulation of gene expression | 6.29% (10/159) | 3.23 | 0.0 | 3e-06 |
GO:0070727 | cellular macromolecule localization | 15.72% (25/159) | 1.73 | 0.0 | 4e-06 |
GO:0140013 | meiotic nuclear division | 5.03% (8/159) | 3.77 | 0.0 | 4e-06 |
GO:0033365 | protein localization to organelle | 10.06% (16/159) | 2.33 | 0.0 | 4e-06 |
GO:0071168 | protein localization to chromatin | 3.14% (5/159) | 5.31 | 0.0 | 4e-06 |
GO:0051276 | chromosome organization | 8.18% (13/159) | 2.66 | 0.0 | 4e-06 |
GO:0048598 | embryonic morphogenesis | 6.92% (11/159) | 2.99 | 0.0 | 4e-06 |
GO:0000791 | euchromatin | 3.77% (6/159) | 4.57 | 0.0 | 5e-06 |
GO:0043543 | protein acylation | 6.29% (10/159) | 3.16 | 0.0 | 5e-06 |
GO:0010646 | regulation of cell communication | 20.75% (33/159) | 1.4 | 0.0 | 5e-06 |
GO:0045595 | regulation of cell differentiation | 10.69% (17/159) | 2.19 | 0.0 | 5e-06 |
GO:0005575 | cellular_component | 79.87% (127/159) | 0.39 | 0.0 | 6e-06 |
GO:0023056 | positive regulation of signaling | 11.95% (19/159) | 2.02 | 0.0 | 6e-06 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 5.66% (9/159) | 3.36 | 0.0 | 6e-06 |
GO:0140097 | catalytic activity, acting on DNA | 6.92% (11/159) | 2.92 | 0.0 | 7e-06 |
GO:0033036 | macromolecule localization | 16.35% (26/159) | 1.63 | 0.0 | 7e-06 |
GO:0000123 | histone acetyltransferase complex | 4.4% (7/159) | 4.01 | 0.0 | 7e-06 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 7.55% (12/159) | 2.74 | 0.0 | 7e-06 |
GO:0031331 | positive regulation of cellular catabolic process | 7.55% (12/159) | 2.73 | 0.0 | 7e-06 |
GO:0003729 | mRNA binding | 14.47% (23/159) | 1.76 | 0.0 | 7e-06 |
GO:0031327 | negative regulation of cellular biosynthetic process | 14.47% (23/159) | 1.76 | 0.0 | 7e-06 |
GO:0048509 | regulation of meristem development | 6.92% (11/159) | 2.9 | 0.0 | 7e-06 |
GO:0034502 | protein localization to chromosome | 3.77% (6/159) | 4.44 | 0.0 | 8e-06 |
GO:0008094 | ATP-dependent activity, acting on DNA | 5.66% (9/159) | 3.31 | 0.0 | 8e-06 |
GO:0140297 | DNA-binding transcription factor binding | 6.92% (11/159) | 2.87 | 0.0 | 8e-06 |
GO:0051253 | negative regulation of RNA metabolic process | 13.21% (21/159) | 1.85 | 0.0 | 9e-06 |
GO:1901360 | organic cyclic compound metabolic process | 32.7% (52/159) | 0.99 | 0.0 | 9e-06 |
GO:0032501 | multicellular organismal process | 34.59% (55/159) | 0.94 | 0.0 | 9e-06 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 13.84% (22/159) | 1.79 | 0.0 | 9e-06 |
GO:0006807 | nitrogen compound metabolic process | 46.54% (74/159) | 0.74 | 0.0 | 9e-06 |
GO:0060840 | artery development | 2.52% (4/159) | 5.94 | 0.0 | 1e-05 |
GO:0080135 | regulation of cellular response to stress | 9.43% (15/159) | 2.3 | 0.0 | 1e-05 |
GO:0005829 | cytosol | 29.56% (47/159) | 1.05 | 1e-06 | 1e-05 |
GO:0043412 | macromolecule modification | 26.42% (42/159) | 1.14 | 0.0 | 1e-05 |
GO:0140657 | ATP-dependent activity | 10.06% (16/159) | 2.2 | 0.0 | 1e-05 |
GO:0023051 | regulation of signaling | 20.13% (32/159) | 1.37 | 1e-06 | 1.1e-05 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 5.66% (9/159) | 3.23 | 1e-06 | 1.2e-05 |
GO:0031248 | protein acetyltransferase complex | 4.4% (7/159) | 3.84 | 1e-06 | 1.3e-05 |
GO:1902493 | acetyltransferase complex | 4.4% (7/159) | 3.84 | 1e-06 | 1.3e-05 |
GO:0031490 | chromatin DNA binding | 4.4% (7/159) | 3.83 | 1e-06 | 1.4e-05 |
GO:0040034 | regulation of development, heterochronic | 6.29% (10/159) | 2.95 | 1e-06 | 1.6e-05 |
GO:0031330 | negative regulation of cellular catabolic process | 5.66% (9/159) | 3.17 | 1e-06 | 1.6e-05 |
GO:0048468 | cell development | 9.43% (15/159) | 2.24 | 1e-06 | 1.6e-05 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 4.4% (7/159) | 3.76 | 1e-06 | 1.8e-05 |
GO:2000058 | regulation of ubiquitin-dependent protein catabolic process | 5.66% (9/159) | 3.15 | 1e-06 | 1.8e-05 |
GO:0005700 | polytene chromosome | 3.77% (6/159) | 4.17 | 1e-06 | 2.1e-05 |
GO:0006997 | nucleus organization | 5.03% (8/159) | 3.38 | 1e-06 | 2.2e-05 |
GO:0008104 | protein localization | 13.84% (22/159) | 1.7 | 1e-06 | 2.3e-05 |
GO:0110165 | cellular anatomical entity | 77.99% (124/159) | 0.37 | 1e-06 | 2.6e-05 |
GO:0034644 | cellular response to UV | 4.4% (7/159) | 3.68 | 1e-06 | 2.6e-05 |
GO:0071216 | cellular response to biotic stimulus | 4.4% (7/159) | 3.68 | 1e-06 | 2.6e-05 |
GO:0042176 | regulation of protein catabolic process | 6.92% (11/159) | 2.68 | 1e-06 | 2.7e-05 |
GO:0016571 | histone methylation | 5.03% (8/159) | 3.33 | 1e-06 | 2.7e-05 |
GO:0035239 | tube morphogenesis | 4.4% (7/159) | 3.66 | 2e-06 | 2.8e-05 |
GO:0044093 | positive regulation of molecular function | 9.43% (15/159) | 2.17 | 2e-06 | 2.8e-05 |
GO:0006284 | base-excision repair | 3.14% (5/159) | 4.68 | 2e-06 | 2.8e-05 |
GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding | 5.66% (9/159) | 3.05 | 2e-06 | 3e-05 |
GO:0043966 | histone H3 acetylation | 3.77% (6/159) | 4.07 | 2e-06 | 3e-05 |
GO:0016607 | nuclear speck | 6.29% (10/159) | 2.82 | 2e-06 | 3.2e-05 |
GO:0061136 | regulation of proteasomal protein catabolic process | 5.66% (9/159) | 3.03 | 2e-06 | 3.3e-05 |
GO:0023057 | negative regulation of signaling | 11.95% (19/159) | 1.83 | 2e-06 | 3.3e-05 |
GO:0010648 | negative regulation of cell communication | 11.95% (19/159) | 1.83 | 2e-06 | 3.3e-05 |
GO:0090068 | positive regulation of cell cycle process | 5.66% (9/159) | 3.02 | 2e-06 | 3.3e-05 |
GO:0051130 | positive regulation of cellular component organization | 8.81% (14/159) | 2.23 | 2e-06 | 3.7e-05 |
GO:0006325 | chromatin organization | 6.92% (11/159) | 2.6 | 2e-06 | 4.1e-05 |
GO:0051168 | nuclear export | 4.4% (7/159) | 3.53 | 3e-06 | 4.8e-05 |
GO:0000118 | histone deacetylase complex | 3.77% (6/159) | 3.94 | 3e-06 | 4.8e-05 |
GO:0043967 | histone H4 acetylation | 3.77% (6/159) | 3.94 | 3e-06 | 4.8e-05 |
GO:0051248 | negative regulation of protein metabolic process | 9.43% (15/159) | 2.09 | 3e-06 | 4.8e-05 |
GO:0010948 | negative regulation of cell cycle process | 5.66% (9/159) | 2.95 | 3e-06 | 5e-05 |
GO:0048506 | regulation of timing of meristematic phase transition | 5.66% (9/159) | 2.94 | 3e-06 | 5.1e-05 |
GO:0048510 | regulation of timing of transition from vegetative to reproductive phase | 5.66% (9/159) | 2.94 | 3e-06 | 5.1e-05 |
GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 6.92% (11/159) | 2.55 | 3e-06 | 5.5e-05 |
GO:0051239 | regulation of multicellular organismal process | 19.5% (31/159) | 1.28 | 3e-06 | 5.5e-05 |
GO:0006405 | RNA export from nucleus | 3.77% (6/159) | 3.9 | 3e-06 | 5.5e-05 |
GO:0036211 | protein modification process | 22.64% (36/159) | 1.15 | 3e-06 | 5.6e-05 |
GO:0009653 | anatomical structure morphogenesis | 20.75% (33/159) | 1.22 | 4e-06 | 5.8e-05 |
GO:0065008 | regulation of biological quality | 24.53% (39/159) | 1.09 | 4e-06 | 5.9e-05 |
GO:1903828 | negative regulation of protein localization | 4.4% (7/159) | 3.46 | 4e-06 | 6.1e-05 |
GO:0048584 | positive regulation of response to stimulus | 16.98% (27/159) | 1.39 | 4e-06 | 6.6e-05 |
GO:0009968 | negative regulation of signal transduction | 11.32% (18/159) | 1.8 | 5e-06 | 7.6e-05 |
GO:0034968 | histone lysine methylation | 4.4% (7/159) | 3.41 | 5e-06 | 7.7e-05 |
GO:0009411 | response to UV | 8.18% (13/159) | 2.21 | 5e-06 | 8.6e-05 |
GO:0061013 | regulation of mRNA catabolic process | 5.03% (8/159) | 3.07 | 6e-06 | 8.9e-05 |
GO:1903050 | regulation of proteolysis involved in protein catabolic process | 5.66% (9/159) | 2.83 | 6e-06 | 9e-05 |
GO:0140030 | modification-dependent protein binding | 4.4% (7/159) | 3.37 | 6e-06 | 9.1e-05 |
GO:0070192 | chromosome organization involved in meiotic cell cycle | 3.77% (6/159) | 3.76 | 6e-06 | 9.1e-05 |
GO:0016922 | nuclear receptor binding | 3.77% (6/159) | 3.76 | 6e-06 | 9.1e-05 |
GO:0010628 | positive regulation of gene expression | 9.43% (15/159) | 2.0 | 6e-06 | 9.2e-05 |
GO:0051101 | regulation of DNA binding | 3.77% (6/159) | 3.73 | 7e-06 | 0.0001 |
GO:1903077 | negative regulation of protein localization to plasma membrane | 2.52% (4/159) | 5.03 | 7e-06 | 0.000101 |
GO:1904376 | negative regulation of protein localization to cell periphery | 2.52% (4/159) | 5.03 | 7e-06 | 0.000101 |
GO:0006479 | protein methylation | 5.03% (8/159) | 3.03 | 7e-06 | 0.000103 |
GO:0008213 | protein alkylation | 5.03% (8/159) | 3.03 | 7e-06 | 0.000103 |
GO:2000026 | regulation of multicellular organismal development | 15.09% (24/159) | 1.46 | 7e-06 | 0.000103 |
GO:1902416 | positive regulation of mRNA binding | 1.89% (3/159) | 6.2 | 8e-06 | 0.000116 |
GO:0010608 | post-transcriptional regulation of gene expression | 8.81% (14/159) | 2.06 | 8e-06 | 0.000119 |
GO:0009895 | negative regulation of catabolic process | 5.66% (9/159) | 2.76 | 9e-06 | 0.000125 |
GO:0051179 | localization | 26.42% (42/159) | 0.98 | 8e-06 | 0.000125 |
GO:0007059 | chromosome segregation | 3.77% (6/159) | 3.67 | 8e-06 | 0.000125 |
GO:0097346 | INO80-type complex | 2.52% (4/159) | 4.94 | 9e-06 | 0.000127 |
GO:0018022 | peptidyl-lysine methylation | 4.4% (7/159) | 3.27 | 9e-06 | 0.000135 |
GO:0009987 | cellular process | 69.18% (110/159) | 0.41 | 1e-05 | 0.000141 |
GO:0045786 | negative regulation of cell cycle | 5.66% (9/159) | 2.73 | 1e-05 | 0.000142 |
GO:0045732 | positive regulation of protein catabolic process | 5.03% (8/159) | 2.96 | 1e-05 | 0.000145 |
GO:2001020 | regulation of response to DNA damage stimulus | 5.03% (8/159) | 2.95 | 1.1e-05 | 0.000152 |
GO:0007474 | imaginal disc-derived wing vein specification | 1.89% (3/159) | 6.07 | 1.1e-05 | 0.000152 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 11.95% (19/159) | 1.65 | 1.1e-05 | 0.000158 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 5.66% (9/159) | 2.7 | 1.2e-05 | 0.000164 |
GO:0050657 | nucleic acid transport | 4.4% (7/159) | 3.2 | 1.2e-05 | 0.000173 |
GO:0050658 | RNA transport | 4.4% (7/159) | 3.2 | 1.2e-05 | 0.000173 |
GO:0070577 | lysine-acetylated histone binding | 2.52% (4/159) | 4.81 | 1.3e-05 | 0.000174 |
GO:0140033 | acetylation-dependent protein binding | 2.52% (4/159) | 4.81 | 1.3e-05 | 0.000174 |
GO:1901987 | regulation of cell cycle phase transition | 6.29% (10/159) | 2.5 | 1.3e-05 | 0.000176 |
GO:0051236 | establishment of RNA localization | 4.4% (7/159) | 3.19 | 1.3e-05 | 0.000177 |
GO:0048513 | animal organ development | 10.06% (16/159) | 1.83 | 1.3e-05 | 0.000177 |
GO:1902415 | regulation of mRNA binding | 1.89% (3/159) | 5.94 | 1.4e-05 | 0.000193 |
GO:0038202 | TORC1 signaling | 1.89% (3/159) | 5.94 | 1.4e-05 | 0.000193 |
GO:0001568 | blood vessel development | 2.52% (4/159) | 4.73 | 1.6e-05 | 0.000213 |
GO:1990428 | miRNA transport | 1.26% (2/159) | 7.94 | 1.6e-05 | 0.000218 |
GO:0003188 | heart valve formation | 1.26% (2/159) | 7.94 | 1.6e-05 | 0.000218 |
GO:0003190 | atrioventricular valve formation | 1.26% (2/159) | 7.94 | 1.6e-05 | 0.000218 |
GO:0003208 | cardiac ventricle morphogenesis | 1.26% (2/159) | 7.94 | 1.6e-05 | 0.000218 |
GO:0043000 | Golgi to plasma membrane CFTR protein transport | 1.26% (2/159) | 7.94 | 1.6e-05 | 0.000218 |
GO:0010821 | regulation of mitochondrion organization | 3.14% (5/159) | 4.0 | 1.6e-05 | 0.00022 |
GO:0006406 | mRNA export from nucleus | 3.14% (5/159) | 3.98 | 1.7e-05 | 0.000229 |
GO:0071217 | cellular response to external biotic stimulus | 1.89% (3/159) | 5.83 | 1.8e-05 | 0.00024 |
GO:0010032 | meiotic chromosome condensation | 1.89% (3/159) | 5.83 | 1.8e-05 | 0.00024 |
GO:0045646 | regulation of erythrocyte differentiation | 2.52% (4/159) | 4.66 | 1.9e-05 | 0.000253 |
GO:0003713 | transcription coactivator activity | 4.4% (7/159) | 3.1 | 2e-05 | 0.000257 |
GO:0044238 | primary metabolic process | 47.8% (76/159) | 0.58 | 2e-05 | 0.000257 |
GO:0050877 | nervous system process | 5.66% (9/159) | 2.6 | 2e-05 | 0.000258 |
GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.14% (5/159) | 3.92 | 2.1e-05 | 0.000268 |
GO:0080134 | regulation of response to stress | 18.24% (29/159) | 1.2 | 2.1e-05 | 0.000269 |
GO:0043488 | regulation of mRNA stability | 4.4% (7/159) | 3.08 | 2.2e-05 | 0.000277 |
GO:0008276 | protein methyltransferase activity | 3.77% (6/159) | 3.43 | 2.2e-05 | 0.000277 |
GO:1905216 | positive regulation of RNA binding | 1.89% (3/159) | 5.72 | 2.3e-05 | 0.000291 |
GO:0035904 | aorta development | 1.89% (3/159) | 5.72 | 2.3e-05 | 0.000291 |
GO:2000648 | positive regulation of stem cell proliferation | 1.89% (3/159) | 5.72 | 2.3e-05 | 0.000291 |
GO:0032774 | RNA biosynthetic process | 5.66% (9/159) | 2.58 | 2.3e-05 | 0.000293 |
GO:0034399 | nuclear periphery | 2.52% (4/159) | 4.58 | 2.4e-05 | 0.000296 |
GO:1905476 | negative regulation of protein localization to membrane | 2.52% (4/159) | 4.55 | 2.6e-05 | 0.000325 |
GO:0065009 | regulation of molecular function | 13.84% (22/159) | 1.42 | 2.6e-05 | 0.000327 |
GO:0031507 | heterochromatin formation | 3.77% (6/159) | 3.37 | 2.8e-05 | 0.000343 |
GO:0000478 | endonucleolytic cleavage involved in rRNA processing | 3.14% (5/159) | 3.84 | 2.8e-05 | 0.000343 |
GO:0005737 | cytoplasm | 20.13% (32/159) | 1.1 | 2.8e-05 | 0.000348 |
GO:0045787 | positive regulation of cell cycle | 5.66% (9/159) | 2.54 | 2.8e-05 | 0.000349 |
GO:0061628 | H3K27me3 modified histone binding | 1.89% (3/159) | 5.62 | 2.9e-05 | 0.000349 |
GO:0070828 | heterochromatin organization | 3.77% (6/159) | 3.36 | 2.9e-05 | 0.000349 |
GO:0008186 | ATP-dependent activity, acting on RNA | 3.77% (6/159) | 3.36 | 2.9e-05 | 0.000349 |
GO:0008170 | N-methyltransferase activity | 3.77% (6/159) | 3.36 | 2.9e-05 | 0.000349 |
GO:0031401 | positive regulation of protein modification process | 6.92% (11/159) | 2.21 | 3e-05 | 0.000363 |
GO:0042127 | regulation of cell population proliferation | 8.81% (14/159) | 1.88 | 3.2e-05 | 0.000381 |
GO:0034660 | ncRNA metabolic process | 9.43% (15/159) | 1.79 | 3.2e-05 | 0.000383 |
GO:0008150 | biological_process | 76.73% (122/159) | 0.32 | 3.3e-05 | 0.00039 |
GO:0051960 | regulation of nervous system development | 4.4% (7/159) | 2.98 | 3.3e-05 | 0.000393 |
GO:0000209 | protein polyubiquitination | 5.03% (8/159) | 2.71 | 3.4e-05 | 0.000403 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.77% (6/159) | 3.31 | 3.5e-05 | 0.00041 |
GO:0051028 | mRNA transport | 3.77% (6/159) | 3.31 | 3.5e-05 | 0.00041 |
GO:1905214 | regulation of RNA binding | 1.89% (3/159) | 5.53 | 3.6e-05 | 0.000411 |
GO:0072091 | regulation of stem cell proliferation | 1.89% (3/159) | 5.53 | 3.6e-05 | 0.000411 |
GO:0060303 | obsolete regulation of nucleosome density | 1.89% (3/159) | 5.53 | 3.6e-05 | 0.000411 |
GO:0010272 | response to silver ion | 1.89% (3/159) | 5.53 | 3.6e-05 | 0.000411 |
GO:0048585 | negative regulation of response to stimulus | 14.47% (23/159) | 1.35 | 3.6e-05 | 0.000416 |
GO:2000241 | regulation of reproductive process | 12.58% (20/159) | 1.47 | 3.7e-05 | 0.000421 |
GO:0003714 | transcription corepressor activity | 3.77% (6/159) | 3.29 | 3.8e-05 | 0.000432 |
GO:0046907 | intracellular transport | 10.69% (17/159) | 1.62 | 4.1e-05 | 0.000465 |
GO:0043487 | regulation of RNA stability | 4.4% (7/159) | 2.93 | 4.2e-05 | 0.000474 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 8.18% (13/159) | 1.93 | 4.2e-05 | 0.000477 |
GO:0007346 | regulation of mitotic cell cycle | 6.29% (10/159) | 2.29 | 4.3e-05 | 0.000481 |
GO:0007140 | male meiotic nuclear division | 3.14% (5/159) | 3.71 | 4.3e-05 | 0.000482 |
GO:0050681 | nuclear androgen receptor binding | 2.52% (4/159) | 4.36 | 4.5e-05 | 0.000501 |
GO:0003674 | molecular_function | 74.84% (119/159) | 0.32 | 4.5e-05 | 0.000508 |
GO:0045814 | negative regulation of gene expression, epigenetic | 3.77% (6/159) | 3.23 | 4.7e-05 | 0.000523 |
GO:1903311 | regulation of mRNA metabolic process | 5.66% (9/159) | 2.44 | 4.9e-05 | 0.000523 |
GO:0003170 | heart valve development | 1.26% (2/159) | 7.36 | 4.9e-05 | 0.000525 |
GO:0060708 | spongiotrophoblast differentiation | 1.26% (2/159) | 7.36 | 4.9e-05 | 0.000525 |
GO:0008098 | 5S rRNA primary transcript binding | 1.26% (2/159) | 7.36 | 4.9e-05 | 0.000525 |
GO:0043578 | nuclear matrix organization | 1.26% (2/159) | 7.36 | 4.9e-05 | 0.000525 |
GO:0097298 | regulation of nucleus size | 1.26% (2/159) | 7.36 | 4.9e-05 | 0.000525 |
GO:0010958 | regulation of amino acid import across plasma membrane | 1.26% (2/159) | 7.36 | 4.9e-05 | 0.000525 |
GO:0032891 | negative regulation of organic acid transport | 1.26% (2/159) | 7.36 | 4.9e-05 | 0.000525 |
GO:0051953 | negative regulation of amine transport | 1.26% (2/159) | 7.36 | 4.9e-05 | 0.000525 |
GO:0051956 | negative regulation of amino acid transport | 1.26% (2/159) | 7.36 | 4.9e-05 | 0.000525 |
GO:1905529 | regulation of uracil import across plasma membrane | 1.26% (2/159) | 7.36 | 4.9e-05 | 0.000525 |
GO:1905530 | negative regulation of uracil import across plasma membrane | 1.26% (2/159) | 7.36 | 4.9e-05 | 0.000525 |
GO:1905532 | regulation of leucine import across plasma membrane | 1.26% (2/159) | 7.36 | 4.9e-05 | 0.000525 |
GO:1905533 | negative regulation of leucine import across plasma membrane | 1.26% (2/159) | 7.36 | 4.9e-05 | 0.000525 |
GO:0018024 | histone-lysine N-methyltransferase activity | 3.14% (5/159) | 3.66 | 5e-05 | 0.000528 |
GO:1903047 | mitotic cell cycle process | 7.55% (12/159) | 2.02 | 4.8e-05 | 0.000529 |
GO:0006282 | regulation of DNA repair | 3.77% (6/159) | 3.21 | 5e-05 | 0.000532 |
GO:0015931 | nucleobase-containing compound transport | 5.03% (8/159) | 2.62 | 5.4e-05 | 0.000566 |
GO:0006417 | regulation of translation | 6.92% (11/159) | 2.11 | 5.6e-05 | 0.000592 |
GO:0016363 | nuclear matrix | 3.14% (5/159) | 3.62 | 5.8e-05 | 0.000603 |
GO:2000060 | positive regulation of ubiquitin-dependent protein catabolic process | 3.77% (6/159) | 3.17 | 6e-05 | 0.000624 |
GO:0006913 | nucleocytoplasmic transport | 4.4% (7/159) | 2.84 | 6.3e-05 | 0.00065 |
GO:0071478 | cellular response to radiation | 6.29% (10/159) | 2.22 | 6.4e-05 | 0.000662 |
GO:0051169 | nuclear transport | 4.4% (7/159) | 2.82 | 6.6e-05 | 0.000681 |
GO:0045892 | negative regulation of DNA-templated transcription | 10.06% (16/159) | 1.62 | 7e-05 | 0.00072 |
GO:0046898 | response to cycloheximide | 1.89% (3/159) | 5.2 | 7.2e-05 | 0.000736 |
GO:0007420 | brain development | 3.77% (6/159) | 3.12 | 7.3e-05 | 0.000746 |
GO:0000469 | cleavage involved in rRNA processing | 3.14% (5/159) | 3.55 | 7.3e-05 | 0.000746 |
GO:1902679 | negative regulation of RNA biosynthetic process | 10.06% (16/159) | 1.61 | 7.6e-05 | 0.000775 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 10.06% (16/159) | 1.61 | 7.6e-05 | 0.000775 |
GO:0070988 | demethylation | 3.14% (5/159) | 3.54 | 7.6e-05 | 0.000775 |
GO:0031056 | regulation of histone modification | 5.03% (8/159) | 2.54 | 7.7e-05 | 0.000778 |
GO:0030575 | nuclear body organization | 1.89% (3/159) | 5.13 | 8.3e-05 | 0.000836 |
GO:1902533 | positive regulation of intracellular signal transduction | 5.66% (9/159) | 2.34 | 8.3e-05 | 0.000836 |
GO:0003006 | developmental process involved in reproduction | 25.79% (41/159) | 0.86 | 8.4e-05 | 0.000845 |
GO:0099080 | supramolecular complex | 8.81% (14/159) | 1.74 | 8.5e-05 | 0.000846 |
GO:0016278 | lysine N-methyltransferase activity | 3.14% (5/159) | 3.5 | 8.7e-05 | 0.000862 |
GO:0016279 | protein-lysine N-methyltransferase activity | 3.14% (5/159) | 3.5 | 8.7e-05 | 0.000862 |
GO:0051568 | histone H3-K4 methylation | 2.52% (4/159) | 4.11 | 8.8e-05 | 0.000871 |
GO:0031981 | nuclear lumen | 3.77% (6/159) | 3.07 | 8.8e-05 | 0.000872 |
GO:0031047 | gene silencing by RNA | 4.4% (7/159) | 2.75 | 8.9e-05 | 0.000873 |
GO:0006338 | chromatin remodeling | 5.03% (8/159) | 2.52 | 8.9e-05 | 0.000874 |
GO:1902692 | regulation of neuroblast proliferation | 1.89% (3/159) | 5.07 | 9.6e-05 | 0.00094 |
GO:0071362 | cellular response to ether | 1.26% (2/159) | 6.94 | 9.8e-05 | 0.000947 |
GO:0072752 | cellular response to rapamycin | 1.26% (2/159) | 6.94 | 9.8e-05 | 0.000947 |
GO:0032116 | SMC loading complex | 1.26% (2/159) | 6.94 | 9.8e-05 | 0.000947 |
GO:0003206 | cardiac chamber morphogenesis | 1.26% (2/159) | 6.94 | 9.8e-05 | 0.000947 |
GO:0061776 | topological DNA co-entrapment activity | 1.26% (2/159) | 6.94 | 9.8e-05 | 0.000947 |
GO:0016574 | histone ubiquitination | 2.52% (4/159) | 4.06 | 0.000101 | 0.00097 |
GO:0034248 | regulation of cellular amide metabolic process | 6.92% (11/159) | 2.01 | 0.000101 | 0.000972 |
GO:1901654 | response to ketone | 3.77% (6/159) | 3.02 | 0.000106 | 0.001016 |
GO:0003281 | ventricular septum development | 1.89% (3/159) | 5.0 | 0.00011 | 0.001048 |
GO:2000179 | positive regulation of neural precursor cell proliferation | 1.89% (3/159) | 5.0 | 0.00011 | 0.001048 |
GO:0010639 | negative regulation of organelle organization | 4.4% (7/159) | 2.7 | 0.000113 | 0.001072 |
GO:0043229 | intracellular organelle | 54.72% (87/159) | 0.45 | 0.000113 | 0.001072 |
GO:0009887 | animal organ morphogenesis | 4.4% (7/159) | 2.69 | 0.000118 | 0.001113 |
GO:0051129 | negative regulation of cellular component organization | 5.66% (9/159) | 2.27 | 0.000118 | 0.001116 |
GO:0019538 | protein metabolic process | 24.53% (39/159) | 0.87 | 0.00012 | 0.001123 |
GO:0042054 | histone methyltransferase activity | 3.14% (5/159) | 3.39 | 0.000121 | 0.001136 |
GO:0031010 | ISWI-type complex | 1.89% (3/159) | 4.94 | 0.000126 | 0.001165 |
GO:0033169 | histone H3-K9 demethylation | 1.89% (3/159) | 4.94 | 0.000126 | 0.001165 |
GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding | 1.89% (3/159) | 4.94 | 0.000126 | 0.001165 |
GO:0030162 | regulation of proteolysis | 6.29% (10/159) | 2.1 | 0.00013 | 0.001207 |
GO:0060341 | regulation of cellular localization | 6.92% (11/159) | 1.97 | 0.000133 | 0.001224 |
GO:0035107 | appendage morphogenesis | 2.52% (4/159) | 3.94 | 0.000139 | 0.001269 |
GO:0030261 | chromosome condensation | 2.52% (4/159) | 3.94 | 0.000139 | 0.001269 |
GO:0019827 | stem cell population maintenance | 6.29% (10/159) | 2.09 | 0.000138 | 0.00127 |
GO:0043226 | organelle | 54.72% (87/159) | 0.45 | 0.000143 | 0.001305 |
GO:1901800 | positive regulation of proteasomal protein catabolic process | 3.77% (6/159) | 2.93 | 0.000146 | 0.001332 |
GO:0051100 | negative regulation of binding | 3.14% (5/159) | 3.32 | 0.000153 | 0.001395 |
GO:0098727 | maintenance of cell number | 6.29% (10/159) | 2.07 | 0.000154 | 0.001397 |
GO:0032880 | regulation of protein localization | 6.29% (10/159) | 2.07 | 0.000156 | 0.001409 |
GO:0048255 | mRNA stabilization | 2.52% (4/159) | 3.9 | 0.000156 | 0.001411 |
GO:0003008 | system process | 6.92% (11/159) | 1.94 | 0.000158 | 0.001419 |
GO:0002521 | leukocyte differentiation | 3.14% (5/159) | 3.31 | 0.000159 | 0.00143 |
GO:0001779 | natural killer cell differentiation | 1.26% (2/159) | 6.62 | 0.000163 | 0.001448 |
GO:1905936 | regulation of germ cell proliferation | 1.26% (2/159) | 6.62 | 0.000163 | 0.001448 |
GO:0001967 | suckling behavior | 1.26% (2/159) | 6.62 | 0.000163 | 0.001448 |
GO:0070973 | protein localization to endoplasmic reticulum exit site | 1.26% (2/159) | 6.62 | 0.000163 | 0.001448 |
GO:0031491 | nucleosome binding | 2.52% (4/159) | 3.88 | 0.000166 | 0.001462 |
GO:0098813 | nuclear chromosome segregation | 2.52% (4/159) | 3.88 | 0.000166 | 0.001462 |
GO:0098687 | chromosomal region | 4.4% (7/159) | 2.6 | 0.000173 | 0.001523 |
GO:0010638 | positive regulation of organelle organization | 5.03% (8/159) | 2.37 | 0.000176 | 0.001535 |
GO:0070076 | histone lysine demethylation | 2.52% (4/159) | 3.85 | 0.000175 | 0.001536 |
GO:0140096 | catalytic activity, acting on a protein | 20.13% (32/159) | 0.96 | 0.000175 | 0.001537 |
GO:0003690 | double-stranded DNA binding | 13.21% (21/159) | 1.27 | 0.000177 | 0.001545 |
GO:0007063 | regulation of sister chromatid cohesion | 1.89% (3/159) | 4.77 | 0.00018 | 0.001564 |
GO:0007010 | cytoskeleton organization | 7.55% (12/159) | 1.81 | 0.000182 | 0.001575 |
GO:0032153 | cell division site | 2.52% (4/159) | 3.83 | 0.000186 | 0.001601 |
GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.52% (4/159) | 3.83 | 0.000186 | 0.001601 |
GO:0031057 | negative regulation of histone modification | 3.14% (5/159) | 3.25 | 0.000192 | 0.001651 |
GO:0016071 | mRNA metabolic process | 8.18% (13/159) | 1.71 | 0.000197 | 0.001693 |
GO:0003279 | cardiac septum development | 1.89% (3/159) | 4.72 | 0.000201 | 0.001699 |
GO:1990814 | DNA/DNA annealing activity | 1.89% (3/159) | 4.72 | 0.000201 | 0.001699 |
GO:0031929 | TOR signaling | 1.89% (3/159) | 4.72 | 0.000201 | 0.001699 |
GO:0030874 | nucleolar chromatin | 1.89% (3/159) | 4.72 | 0.000201 | 0.001699 |
GO:0003724 | RNA helicase activity | 3.14% (5/159) | 3.24 | 0.000199 | 0.001703 |
GO:1990904 | ribonucleoprotein complex | 8.81% (14/159) | 1.62 | 0.0002 | 0.001713 |
GO:0031400 | negative regulation of protein modification process | 5.03% (8/159) | 2.34 | 0.000206 | 0.001737 |
GO:0007062 | sister chromatid cohesion | 2.52% (4/159) | 3.79 | 0.000207 | 0.00174 |
GO:0016577 | histone demethylation | 2.52% (4/159) | 3.79 | 0.000207 | 0.00174 |
GO:0070647 | protein modification by small protein conjugation or removal | 9.43% (15/159) | 1.55 | 0.00021 | 0.001758 |
GO:2000105 | positive regulation of DNA-templated DNA replication | 1.89% (3/159) | 4.67 | 0.000223 | 0.001857 |
GO:0016581 | NuRD complex | 1.89% (3/159) | 4.67 | 0.000223 | 0.001857 |
GO:0090545 | CHD-type complex | 1.89% (3/159) | 4.67 | 0.000223 | 0.001857 |
GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 5.03% (8/159) | 2.3 | 0.00024 | 0.001992 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 5.03% (8/159) | 2.3 | 0.000244 | 0.001992 |
GO:0035041 | sperm DNA decondensation | 1.26% (2/159) | 6.36 | 0.000244 | 0.001996 |
GO:0030101 | natural killer cell activation | 1.26% (2/159) | 6.36 | 0.000244 | 0.001996 |
GO:0060707 | trophoblast giant cell differentiation | 1.26% (2/159) | 6.36 | 0.000244 | 0.001996 |
GO:0042675 | compound eye cone cell differentiation | 1.26% (2/159) | 6.36 | 0.000244 | 0.001996 |
GO:0000445 | THO complex part of transcription export complex | 1.26% (2/159) | 6.36 | 0.000244 | 0.001996 |
GO:0099115 | chromosome, subtelomeric region | 1.26% (2/159) | 6.36 | 0.000244 | 0.001996 |
GO:1903052 | positive regulation of proteolysis involved in protein catabolic process | 3.77% (6/159) | 2.79 | 0.000255 | 0.00208 |
GO:0051649 | establishment of localization in cell | 10.69% (17/159) | 1.4 | 0.000265 | 0.00215 |
GO:0035770 | ribonucleoprotein granule | 5.03% (8/159) | 2.28 | 0.00027 | 0.002161 |
GO:0071310 | cellular response to organic substance | 10.69% (17/159) | 1.4 | 0.000271 | 0.002162 |
GO:0035064 | methylated histone binding | 2.52% (4/159) | 3.69 | 0.000269 | 0.002162 |
GO:0140034 | methylation-dependent protein binding | 2.52% (4/159) | 3.69 | 0.000269 | 0.002162 |
GO:1902373 | negative regulation of mRNA catabolic process | 2.52% (4/159) | 3.69 | 0.000269 | 0.002162 |
GO:0006482 | protein demethylation | 2.52% (4/159) | 3.69 | 0.000269 | 0.002162 |
GO:0008214 | protein dealkylation | 2.52% (4/159) | 3.69 | 0.000269 | 0.002162 |
GO:0034470 | ncRNA processing | 7.55% (12/159) | 1.75 | 0.000271 | 0.002163 |
GO:0016584 | obsolete nucleosome positioning | 1.89% (3/159) | 4.57 | 0.000273 | 0.002167 |
GO:0048514 | blood vessel morphogenesis | 1.89% (3/159) | 4.57 | 0.000273 | 0.002167 |
GO:0007051 | spindle organization | 3.77% (6/159) | 2.76 | 0.000282 | 0.002233 |
GO:1901988 | negative regulation of cell cycle phase transition | 3.77% (6/159) | 2.75 | 0.000296 | 0.002334 |
GO:0007281 | germ cell development | 3.77% (6/159) | 2.75 | 0.000296 | 0.002334 |
GO:0040028 | regulation of vulval development | 1.89% (3/159) | 4.53 | 0.0003 | 0.002362 |
GO:0045862 | positive regulation of proteolysis | 4.4% (7/159) | 2.46 | 0.000312 | 0.002447 |
GO:0008589 | regulation of smoothened signaling pathway | 2.52% (4/159) | 3.62 | 0.000328 | 0.002566 |
GO:0140666 | annealing activity | 1.89% (3/159) | 4.48 | 0.000329 | 0.002573 |
GO:0090297 | positive regulation of mitochondrial DNA replication | 1.26% (2/159) | 6.13 | 0.000341 | 0.002643 |
GO:1901860 | positive regulation of mitochondrial DNA metabolic process | 1.26% (2/159) | 6.13 | 0.000341 | 0.002643 |
GO:0034401 | obsolete chromatin organization involved in regulation of transcription | 1.26% (2/159) | 6.13 | 0.000341 | 0.002643 |
GO:0044877 | protein-containing complex binding | 8.18% (13/159) | 1.62 | 0.000342 | 0.002646 |
GO:0006397 | mRNA processing | 5.66% (9/159) | 2.06 | 0.000351 | 0.002712 |
GO:0009790 | embryo development | 10.06% (16/159) | 1.42 | 0.000354 | 0.002727 |
GO:0044237 | cellular metabolic process | 47.17% (75/159) | 0.48 | 0.000356 | 0.002733 |
GO:0000987 | cis-regulatory region sequence-specific DNA binding | 5.66% (9/159) | 2.05 | 0.000356 | 0.002737 |
GO:0017148 | negative regulation of translation | 3.77% (6/159) | 2.69 | 0.000358 | 0.002741 |
GO:0045132 | meiotic chromosome segregation | 1.89% (3/159) | 4.44 | 0.00036 | 0.002751 |
GO:0051090 | regulation of DNA-binding transcription factor activity | 3.77% (6/159) | 2.67 | 0.000384 | 0.002925 |
GO:0006368 | transcription elongation by RNA polymerase II promoter | 1.89% (3/159) | 4.4 | 0.000393 | 0.002961 |
GO:0070461 | SAGA-type complex | 1.89% (3/159) | 4.4 | 0.000393 | 0.002961 |
GO:0001947 | heart looping | 1.89% (3/159) | 4.4 | 0.000393 | 0.002961 |
GO:0003143 | embryonic heart tube morphogenesis | 1.89% (3/159) | 4.4 | 0.000393 | 0.002961 |
GO:1902532 | negative regulation of intracellular signal transduction | 5.03% (8/159) | 2.2 | 0.00039 | 0.002961 |
GO:0045637 | regulation of myeloid cell differentiation | 2.52% (4/159) | 3.53 | 0.000413 | 0.003107 |
GO:0045472 | response to ether | 1.89% (3/159) | 4.36 | 0.000427 | 0.003206 |
GO:0010506 | regulation of autophagy | 3.77% (6/159) | 2.64 | 0.00044 | 0.003292 |
GO:0016590 | ACF complex | 1.26% (2/159) | 5.94 | 0.000453 | 0.003341 |
GO:0046020 | obsolete negative regulation of transcription from RNA polymerase II promoter by pheromones | 1.26% (2/159) | 5.94 | 0.000453 | 0.003341 |
GO:0090537 | CERF complex | 1.26% (2/159) | 5.94 | 0.000453 | 0.003341 |
GO:0036121 | double-stranded DNA helicase activity | 1.26% (2/159) | 5.94 | 0.000453 | 0.003341 |
GO:0060218 | hematopoietic stem cell differentiation | 1.26% (2/159) | 5.94 | 0.000453 | 0.003341 |
GO:1903427 | negative regulation of reactive oxygen species biosynthetic process | 1.26% (2/159) | 5.94 | 0.000453 | 0.003341 |
GO:0034649 | obsolete histone demethylase activity (H3-monomethyl-K4 specific) | 1.26% (2/159) | 5.94 | 0.000453 | 0.003341 |
GO:0034249 | negative regulation of cellular amide metabolic process | 3.77% (6/159) | 2.63 | 0.00046 | 0.003375 |
GO:0006302 | double-strand break repair | 3.77% (6/159) | 2.63 | 0.00046 | 0.003375 |
GO:0005730 | nucleolus | 9.43% (15/159) | 1.44 | 0.000464 | 0.003388 |
GO:0043024 | ribosomal small subunit binding | 1.89% (3/159) | 4.32 | 0.000464 | 0.00339 |
GO:0045740 | positive regulation of DNA replication | 1.89% (3/159) | 4.32 | 0.000464 | 0.00339 |
GO:0050821 | protein stabilization | 3.77% (6/159) | 2.61 | 0.00048 | 0.003496 |
GO:0030098 | lymphocyte differentiation | 2.52% (4/159) | 3.47 | 0.000492 | 0.003559 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 2.52% (4/159) | 3.47 | 0.000492 | 0.003559 |
GO:0006352 | DNA-templated transcription initiation | 2.52% (4/159) | 3.47 | 0.000492 | 0.003559 |
GO:2000677 | regulation of transcription regulatory region DNA binding | 1.89% (3/159) | 4.28 | 0.000502 | 0.003623 |
GO:0004843 | cysteine-type deubiquitinase activity | 2.52% (4/159) | 3.45 | 0.000513 | 0.003698 |
GO:0070918 | small regulatory ncRNA processing | 3.14% (5/159) | 2.94 | 0.000517 | 0.003707 |
GO:0010212 | response to ionizing radiation | 3.14% (5/159) | 2.94 | 0.000517 | 0.003707 |
GO:0030307 | positive regulation of cell growth | 3.77% (6/159) | 2.59 | 0.000524 | 0.003749 |
GO:0140718 | facultative heterochromatin formation | 2.52% (4/159) | 3.43 | 0.000535 | 0.003823 |
GO:2000779 | regulation of double-strand break repair | 2.52% (4/159) | 3.42 | 0.000558 | 0.003976 |
GO:0010494 | cytoplasmic stress granule | 3.14% (5/159) | 2.91 | 0.000562 | 0.003992 |
GO:0000932 | P-body | 3.14% (5/159) | 2.91 | 0.000562 | 0.003992 |
GO:0009909 | regulation of flower development | 6.29% (10/159) | 1.83 | 0.000571 | 0.004045 |
GO:0071425 | hematopoietic stem cell proliferation | 1.26% (2/159) | 5.77 | 0.000581 | 0.004067 |
GO:0031213 | RSF complex | 1.26% (2/159) | 5.77 | 0.000581 | 0.004067 |
GO:0008190 | eukaryotic initiation factor 4E binding | 1.26% (2/159) | 5.77 | 0.000581 | 0.004067 |
GO:0090296 | regulation of mitochondrial DNA replication | 1.26% (2/159) | 5.77 | 0.000581 | 0.004067 |
GO:1901858 | regulation of mitochondrial DNA metabolic process | 1.26% (2/159) | 5.77 | 0.000581 | 0.004067 |
GO:0031931 | TORC1 complex | 1.26% (2/159) | 5.77 | 0.000581 | 0.004067 |
GO:0045639 | positive regulation of myeloid cell differentiation | 1.89% (3/159) | 4.2 | 0.000584 | 0.004073 |
GO:0045070 | positive regulation of viral genome replication | 1.89% (3/159) | 4.2 | 0.000584 | 0.004073 |
GO:0043565 | sequence-specific DNA binding | 13.21% (21/159) | 1.13 | 0.000587 | 0.004084 |
GO:0031048 | small non-coding RNA-dependent heterochromatin formation | 2.52% (4/159) | 3.39 | 0.000605 | 0.0042 |
GO:2001251 | negative regulation of chromosome organization | 2.52% (4/159) | 3.37 | 0.000629 | 0.004335 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.52% (4/159) | 3.37 | 0.000629 | 0.004335 |
GO:1903076 | regulation of protein localization to plasma membrane | 2.52% (4/159) | 3.37 | 0.000629 | 0.004335 |
GO:0043489 | RNA stabilization | 2.52% (4/159) | 3.37 | 0.000629 | 0.004335 |
GO:0002009 | morphogenesis of an epithelium | 3.14% (5/159) | 2.86 | 0.000662 | 0.00455 |
GO:0006310 | DNA recombination | 3.77% (6/159) | 2.52 | 0.000672 | 0.004612 |
GO:0005816 | spindle pole body | 1.89% (3/159) | 4.13 | 0.000675 | 0.004621 |
GO:0071482 | cellular response to light stimulus | 5.03% (8/159) | 2.07 | 0.000699 | 0.004775 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 1.26% (2/159) | 5.62 | 0.000724 | 0.004806 |
GO:1901355 | response to rapamycin | 1.26% (2/159) | 5.62 | 0.000724 | 0.004806 |
GO:0005652 | nuclear lamina | 1.26% (2/159) | 5.62 | 0.000724 | 0.004806 |
GO:0030220 | platelet formation | 1.26% (2/159) | 5.62 | 0.000724 | 0.004806 |
GO:0043426 | MRF binding | 1.26% (2/159) | 5.62 | 0.000724 | 0.004806 |
GO:0010635 | regulation of mitochondrial fusion | 1.26% (2/159) | 5.62 | 0.000724 | 0.004806 |
GO:0010637 | negative regulation of mitochondrial fusion | 1.26% (2/159) | 5.62 | 0.000724 | 0.004806 |
GO:0098779 | positive regulation of mitophagy in response to mitochondrial depolarization | 1.26% (2/159) | 5.62 | 0.000724 | 0.004806 |
GO:1903789 | regulation of amino acid transmembrane transport | 1.26% (2/159) | 5.62 | 0.000724 | 0.004806 |
GO:1904923 | regulation of autophagy of mitochondrion in response to mitochondrial depolarization | 1.26% (2/159) | 5.62 | 0.000724 | 0.004806 |
GO:1904925 | positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization | 1.26% (2/159) | 5.62 | 0.000724 | 0.004806 |
GO:1990391 | DNA repair complex | 1.26% (2/159) | 5.62 | 0.000724 | 0.004806 |
GO:0030435 | sporulation resulting in formation of a cellular spore | 2.52% (4/159) | 3.33 | 0.000707 | 0.004825 |
GO:0043388 | positive regulation of DNA binding | 1.89% (3/159) | 4.1 | 0.000723 | 0.004913 |
GO:0048562 | embryonic organ morphogenesis | 1.89% (3/159) | 4.1 | 0.000723 | 0.004913 |
GO:0016236 | macroautophagy | 2.52% (4/159) | 3.3 | 0.000763 | 0.005055 |
GO:1903131 | mononuclear cell differentiation | 2.52% (4/159) | 3.28 | 0.000792 | 0.005226 |
GO:0101005 | deubiquitinase activity | 2.52% (4/159) | 3.28 | 0.000792 | 0.005226 |
GO:1904375 | regulation of protein localization to cell periphery | 2.52% (4/159) | 3.24 | 0.000884 | 0.005626 |
GO:1901796 | regulation of signal transduction by p53 class mediator | 2.52% (4/159) | 3.24 | 0.000884 | 0.005626 |
GO:1902036 | regulation of hematopoietic stem cell differentiation | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:0060194 | regulation of antisense RNA transcription | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:0060195 | negative regulation of antisense RNA transcription | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:0000340 | RNA 7-methylguanosine cap binding | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:0010712 | regulation of collagen metabolic process | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:0010714 | positive regulation of collagen metabolic process | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:0032965 | regulation of collagen biosynthetic process | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:0032967 | positive regulation of collagen biosynthetic process | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:0010484 | H3 histone acetyltransferase activity | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:0051955 | regulation of amino acid transport | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:0098780 | response to mitochondrial depolarisation | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:0070412 | R-SMAD binding | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:0038201 | TOR complex | 1.26% (2/159) | 5.48 | 0.000883 | 0.005641 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 3.14% (5/159) | 2.78 | 0.000857 | 0.005644 |
GO:0042981 | regulation of apoptotic process | 6.29% (10/159) | 1.74 | 0.000894 | 0.005669 |
GO:0048831 | regulation of shoot system development | 6.29% (10/159) | 1.74 | 0.000894 | 0.005669 |
GO:0071345 | cellular response to cytokine stimulus | 3.77% (6/159) | 2.45 | 0.000868 | 0.005707 |
GO:0010492 | maintenance of shoot apical meristem identity | 2.52% (4/159) | 3.23 | 0.000916 | 0.005766 |
GO:0030490 | maturation of SSU-rRNA | 2.52% (4/159) | 3.23 | 0.000916 | 0.005766 |
GO:1902369 | negative regulation of RNA catabolic process | 2.52% (4/159) | 3.23 | 0.000916 | 0.005766 |
GO:1903312 | negative regulation of mRNA metabolic process | 2.52% (4/159) | 3.23 | 0.000916 | 0.005766 |
GO:0031061 | negative regulation of histone methylation | 1.89% (3/159) | 4.0 | 0.000882 | 0.005784 |
GO:0045069 | regulation of viral genome replication | 1.89% (3/159) | 3.97 | 0.000939 | 0.005891 |
GO:0008284 | positive regulation of cell population proliferation | 5.03% (8/159) | 2.0 | 0.000939 | 0.005901 |
GO:0048666 | neuron development | 2.52% (4/159) | 3.21 | 0.000949 | 0.005941 |
GO:0007626 | locomotory behavior | 2.52% (4/159) | 3.2 | 0.000983 | 0.006141 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 1.89% (3/159) | 3.94 | 0.000999 | 0.006231 |
GO:0140110 | transcription regulator activity | 11.95% (19/159) | 1.14 | 0.001021 | 0.006361 |
GO:0061587 | transfer RNA gene-mediated silencing | 1.26% (2/159) | 5.36 | 0.001057 | 0.00644 |
GO:0008623 | CHRAC | 1.26% (2/159) | 5.36 | 0.001057 | 0.00644 |
GO:0035063 | nuclear speck organization | 1.26% (2/159) | 5.36 | 0.001057 | 0.00644 |
GO:0035092 | sperm DNA condensation | 1.26% (2/159) | 5.36 | 0.001057 | 0.00644 |
GO:0031315 | extrinsic component of mitochondrial outer membrane | 1.26% (2/159) | 5.36 | 0.001057 | 0.00644 |
GO:0017108 | 5'-flap endonuclease activity | 1.26% (2/159) | 5.36 | 0.001057 | 0.00644 |
GO:0000182 | rDNA binding | 1.26% (2/159) | 5.36 | 0.001057 | 0.00644 |
GO:0046695 | SLIK (SAGA-like) complex | 1.26% (2/159) | 5.36 | 0.001057 | 0.00644 |
GO:2000616 | negative regulation of histone H3-K9 acetylation | 1.26% (2/159) | 5.36 | 0.001057 | 0.00644 |
GO:0031641 | regulation of myelination | 1.26% (2/159) | 5.36 | 0.001057 | 0.00644 |
GO:0051952 | regulation of amine transport | 1.26% (2/159) | 5.36 | 0.001057 | 0.00644 |
GO:0034648 | obsolete histone demethylase activity (H3-dimethyl-K4 specific) | 1.26% (2/159) | 5.36 | 0.001057 | 0.00644 |
GO:0006354 | DNA-templated transcription elongation | 1.89% (3/159) | 3.91 | 0.001061 | 0.006443 |
GO:0008013 | beta-catenin binding | 1.89% (3/159) | 3.91 | 0.001061 | 0.006443 |
GO:0031647 | regulation of protein stability | 4.4% (7/159) | 2.16 | 0.001072 | 0.006501 |
GO:0071214 | cellular response to abiotic stimulus | 7.55% (12/159) | 1.52 | 0.001089 | 0.006557 |
GO:0104004 | cellular response to environmental stimulus | 7.55% (12/159) | 1.52 | 0.001089 | 0.006557 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 3.77% (6/159) | 2.39 | 0.001086 | 0.006572 |
GO:0050792 | regulation of viral process | 2.52% (4/159) | 3.16 | 0.001089 | 0.006579 |
GO:0019787 | ubiquitin-like protein transferase activity | 6.29% (10/159) | 1.7 | 0.001115 | 0.006704 |
GO:0007276 | gamete generation | 4.4% (7/159) | 2.14 | 0.001138 | 0.006826 |
GO:0022607 | cellular component assembly | 13.21% (21/159) | 1.06 | 0.001143 | 0.006846 |
GO:0050896 | response to stimulus | 50.94% (81/159) | 0.4 | 0.001152 | 0.00689 |
GO:0006261 | DNA-templated DNA replication | 2.52% (4/159) | 3.13 | 0.001164 | 0.006936 |
GO:0016887 | ATP hydrolysis activity | 2.52% (4/159) | 3.13 | 0.001164 | 0.006936 |
GO:0019899 | enzyme binding | 11.95% (19/159) | 1.12 | 0.001184 | 0.007042 |
GO:0015616 | DNA translocase activity | 1.26% (2/159) | 5.24 | 0.001245 | 0.007306 |
GO:0001227 | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.26% (2/159) | 5.24 | 0.001245 | 0.007306 |
GO:0046782 | regulation of viral transcription | 1.26% (2/159) | 5.24 | 0.001245 | 0.007306 |
GO:0007608 | sensory perception of smell | 1.26% (2/159) | 5.24 | 0.001245 | 0.007306 |
GO:0080009 | mRNA methylation | 1.26% (2/159) | 5.24 | 0.001245 | 0.007306 |
GO:0000347 | THO complex | 1.26% (2/159) | 5.24 | 0.001245 | 0.007306 |
GO:0090308 | regulation of DNA methylation-dependent heterochromatin formation | 1.26% (2/159) | 5.24 | 0.001245 | 0.007306 |
GO:0090309 | positive regulation of DNA methylation-dependent heterochromatin formation | 1.26% (2/159) | 5.24 | 0.001245 | 0.007306 |
GO:0007031 | peroxisome organization | 1.89% (3/159) | 3.83 | 0.001261 | 0.007386 |
GO:0051091 | positive regulation of DNA-binding transcription factor activity | 2.52% (4/159) | 3.1 | 0.001284 | 0.00748 |
GO:0008283 | cell population proliferation | 3.14% (5/159) | 2.65 | 0.001283 | 0.00749 |
GO:0006260 | DNA replication | 3.14% (5/159) | 2.65 | 0.001283 | 0.00749 |
GO:0016567 | protein ubiquitination | 7.55% (12/159) | 1.48 | 0.001323 | 0.007697 |
GO:0001221 | transcription coregulator binding | 1.89% (3/159) | 3.8 | 0.001333 | 0.00774 |
GO:0031445 | regulation of heterochromatin formation | 1.89% (3/159) | 3.77 | 0.001407 | 0.008144 |
GO:0120261 | regulation of heterochromatin organization | 1.89% (3/159) | 3.77 | 0.001407 | 0.008144 |
GO:0048729 | tissue morphogenesis | 3.14% (5/159) | 2.61 | 0.001434 | 0.008271 |
GO:0061630 | ubiquitin protein ligase activity | 4.4% (7/159) | 2.08 | 0.001432 | 0.008273 |
GO:0016589 | NURF complex | 1.26% (2/159) | 5.13 | 0.001449 | 0.00829 |
GO:0035076 | ecdysone receptor-mediated signaling pathway | 1.26% (2/159) | 5.13 | 0.001449 | 0.00829 |
GO:0001172 | RNA-templated transcription | 1.26% (2/159) | 5.13 | 0.001449 | 0.00829 |
GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor | 1.26% (2/159) | 5.13 | 0.001449 | 0.00829 |
GO:0000812 | Swr1 complex | 1.26% (2/159) | 5.13 | 0.001449 | 0.00829 |
GO:0045930 | negative regulation of mitotic cell cycle | 3.14% (5/159) | 2.61 | 0.001465 | 0.008342 |
GO:0051783 | regulation of nuclear division | 3.14% (5/159) | 2.61 | 0.001465 | 0.008342 |
GO:0048732 | gland development | 3.14% (5/159) | 2.61 | 0.001465 | 0.008342 |
GO:0090329 | regulation of DNA-templated DNA replication | 2.52% (4/159) | 3.03 | 0.001502 | 0.008533 |
GO:0030099 | myeloid cell differentiation | 2.52% (4/159) | 3.02 | 0.001548 | 0.008783 |
GO:0061659 | ubiquitin-like protein ligase activity | 4.4% (7/159) | 2.06 | 0.001599 | 0.009059 |
GO:2000628 | regulation of miRNA metabolic process | 1.26% (2/159) | 5.03 | 0.001667 | 0.009368 |
GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters | 1.26% (2/159) | 5.03 | 0.001667 | 0.009368 |
GO:0048256 | flap endonuclease activity | 1.26% (2/159) | 5.03 | 0.001667 | 0.009368 |
GO:1990414 | replication-born double-strand break repair via sister chromatid exchange | 1.26% (2/159) | 5.03 | 0.001667 | 0.009368 |
GO:0051573 | negative regulation of histone H3-K9 methylation | 1.26% (2/159) | 5.03 | 0.001667 | 0.009368 |
GO:0045597 | positive regulation of cell differentiation | 4.4% (7/159) | 2.04 | 0.001689 | 0.009472 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 6.29% (10/159) | 1.62 | 0.001694 | 0.009486 |
GO:0009561 | megagametogenesis | 1.89% (3/159) | 3.67 | 0.00173 | 0.00967 |
GO:0032446 | protein modification by small protein conjugation | 7.55% (12/159) | 1.43 | 0.001792 | 0.010001 |
GO:0019783 | ubiquitin-like protein peptidase activity | 2.52% (4/159) | 2.96 | 0.001795 | 0.010006 |
GO:0051784 | negative regulation of nuclear division | 1.89% (3/159) | 3.64 | 0.001817 | 0.010109 |
GO:1905475 | regulation of protein localization to membrane | 2.52% (4/159) | 2.95 | 0.001848 | 0.010249 |
GO:0035097 | histone methyltransferase complex | 2.52% (4/159) | 2.95 | 0.001848 | 0.010249 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.89% (3/159) | 3.62 | 0.001907 | 0.010457 |
GO:0045927 | positive regulation of growth | 4.4% (7/159) | 2.01 | 0.001904 | 0.010459 |
GO:0000781 | chromosome, telomeric region | 2.52% (4/159) | 2.94 | 0.001902 | 0.010462 |
GO:0000339 | RNA cap binding | 1.26% (2/159) | 4.94 | 0.001901 | 0.010473 |
GO:0072520 | seminiferous tubule development | 1.26% (2/159) | 4.94 | 0.001901 | 0.010473 |
GO:0010823 | negative regulation of mitochondrion organization | 1.26% (2/159) | 4.94 | 0.001901 | 0.010473 |
GO:0045875 | negative regulation of sister chromatid cohesion | 1.26% (2/159) | 4.94 | 0.001901 | 0.010473 |
GO:0009792 | embryo development ending in birth or egg hatching | 3.77% (6/159) | 2.22 | 0.001932 | 0.010581 |
GO:0043067 | regulation of programmed cell death | 7.55% (12/159) | 1.42 | 0.001946 | 0.010639 |
GO:1903706 | regulation of hemopoiesis | 2.52% (4/159) | 2.92 | 0.002012 | 0.010948 |
GO:0065004 | protein-DNA complex assembly | 2.52% (4/159) | 2.92 | 0.002012 | 0.010948 |
GO:0046649 | lymphocyte activation | 2.52% (4/159) | 2.92 | 0.002012 | 0.010948 |
GO:0010562 | positive regulation of phosphorus metabolic process | 3.77% (6/159) | 2.21 | 0.002026 | 0.010988 |
GO:0045937 | positive regulation of phosphate metabolic process | 3.77% (6/159) | 2.21 | 0.002026 | 0.010988 |
GO:0010033 | response to organic substance | 27.67% (44/159) | 0.61 | 0.002078 | 0.011254 |
GO:0009793 | embryo development ending in seed dormancy | 7.55% (12/159) | 1.4 | 0.002096 | 0.011332 |
GO:0001558 | regulation of cell growth | 6.29% (10/159) | 1.58 | 0.0021 | 0.011335 |
GO:0002209 | behavioral defense response | 1.26% (2/159) | 4.85 | 0.002148 | 0.011524 |
GO:0000395 | mRNA 5'-splice site recognition | 1.26% (2/159) | 4.85 | 0.002148 | 0.011524 |
GO:0045947 | negative regulation of translational initiation | 1.26% (2/159) | 4.85 | 0.002148 | 0.011524 |
GO:0043968 | histone H2A acetylation | 1.26% (2/159) | 4.85 | 0.002148 | 0.011524 |
GO:0048524 | positive regulation of viral process | 1.89% (3/159) | 3.55 | 0.002193 | 0.011729 |
GO:0048731 | system development | 7.55% (12/159) | 1.4 | 0.00219 | 0.011731 |
GO:0051054 | positive regulation of DNA metabolic process | 3.14% (5/159) | 2.46 | 0.002256 | 0.012044 |
GO:0090066 | regulation of anatomical structure size | 3.77% (6/159) | 2.16 | 0.002362 | 0.012594 |
GO:0140098 | catalytic activity, acting on RNA | 5.66% (9/159) | 1.66 | 0.002376 | 0.012648 |
GO:0005849 | mRNA cleavage factor complex | 1.89% (3/159) | 3.5 | 0.002398 | 0.012706 |
GO:0048027 | mRNA 5'-UTR binding | 1.89% (3/159) | 3.5 | 0.002398 | 0.012706 |
GO:0060562 | epithelial tube morphogenesis | 1.89% (3/159) | 3.5 | 0.002398 | 0.012706 |
GO:0098760 | response to interleukin-7 | 1.26% (2/159) | 4.77 | 0.00241 | 0.012713 |
GO:0098761 | cellular response to interleukin-7 | 1.26% (2/159) | 4.77 | 0.00241 | 0.012713 |
GO:0048188 | Set1C/COMPASS complex | 1.26% (2/159) | 4.77 | 0.00241 | 0.012713 |
GO:0045727 | positive regulation of translation | 3.14% (5/159) | 2.44 | 0.002436 | 0.012826 |
GO:0006914 | autophagy | 3.14% (5/159) | 2.43 | 0.002482 | 0.013052 |
GO:0040020 | regulation of meiotic nuclear division | 1.89% (3/159) | 3.48 | 0.002505 | 0.01313 |
GO:1903900 | regulation of viral life cycle | 1.89% (3/159) | 3.48 | 0.002505 | 0.01313 |
GO:0003678 | DNA helicase activity | 2.52% (4/159) | 2.82 | 0.002565 | 0.013424 |
GO:0043066 | negative regulation of apoptotic process | 4.4% (7/159) | 1.93 | 0.002583 | 0.0135 |
GO:0031060 | regulation of histone methylation | 3.14% (5/159) | 2.41 | 0.002626 | 0.013702 |
GO:0007098 | centrosome cycle | 1.26% (2/159) | 4.69 | 0.002687 | 0.013831 |
GO:0021895 | cerebral cortex neuron differentiation | 1.26% (2/159) | 4.69 | 0.002687 | 0.013831 |
GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.26% (2/159) | 4.69 | 0.002687 | 0.013831 |
GO:0006598 | polyamine catabolic process | 1.26% (2/159) | 4.69 | 0.002687 | 0.013831 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.26% (2/159) | 4.69 | 0.002687 | 0.013831 |
GO:0043189 | H4/H2A histone acetyltransferase complex | 1.26% (2/159) | 4.69 | 0.002687 | 0.013831 |
GO:0070971 | endoplasmic reticulum exit site | 1.26% (2/159) | 4.69 | 0.002687 | 0.013831 |
GO:0008152 | metabolic process | 50.94% (81/159) | 0.36 | 0.002662 | 0.013872 |
GO:0061919 | process utilizing autophagic mechanism | 3.14% (5/159) | 2.41 | 0.002675 | 0.013917 |
GO:0000151 | ubiquitin ligase complex | 4.4% (7/159) | 1.92 | 0.002746 | 0.014113 |
GO:0009910 | negative regulation of flower development | 2.52% (4/159) | 2.79 | 0.00277 | 0.014217 |
GO:0018105 | peptidyl-serine phosphorylation | 3.14% (5/159) | 2.39 | 0.002775 | 0.014224 |
GO:0071479 | cellular response to ionizing radiation | 1.89% (3/159) | 3.42 | 0.002843 | 0.014547 |
GO:0045746 | negative regulation of Notch signaling pathway | 1.26% (2/159) | 4.62 | 0.002977 | 0.015102 |
GO:0000001 | mitochondrion inheritance | 1.26% (2/159) | 4.62 | 0.002977 | 0.015102 |
GO:2000615 | regulation of histone H3-K9 acetylation | 1.26% (2/159) | 4.62 | 0.002977 | 0.015102 |
GO:0043981 | histone H4-K5 acetylation | 1.26% (2/159) | 4.62 | 0.002977 | 0.015102 |
GO:2000736 | regulation of stem cell differentiation | 1.89% (3/159) | 3.4 | 0.002961 | 0.015108 |
GO:0000775 | chromosome, centromeric region | 1.89% (3/159) | 3.4 | 0.002961 | 0.015108 |
GO:0001666 | response to hypoxia | 5.03% (8/159) | 1.74 | 0.002986 | 0.015121 |
GO:0009314 | response to radiation | 14.47% (23/159) | 0.89 | 0.003041 | 0.015382 |
GO:0004842 | ubiquitin-protein transferase activity | 5.66% (9/159) | 1.6 | 0.00308 | 0.015554 |
GO:0043025 | neuronal cell body | 3.14% (5/159) | 2.36 | 0.003093 | 0.015596 |
GO:0034097 | response to cytokine | 3.77% (6/159) | 2.08 | 0.00316 | 0.015908 |
GO:0017053 | transcription repressor complex | 1.89% (3/159) | 3.36 | 0.003207 | 0.016125 |
GO:0015630 | microtubule cytoskeleton | 2.52% (4/159) | 2.73 | 0.003214 | 0.016133 |
GO:0006611 | protein export from nucleus | 1.26% (2/159) | 4.55 | 0.003282 | 0.01631 |
GO:0000779 | condensed chromosome, centromeric region | 1.26% (2/159) | 4.55 | 0.003282 | 0.01631 |
GO:0031011 | Ino80 complex | 1.26% (2/159) | 4.55 | 0.003282 | 0.01631 |
GO:0046966 | nuclear thyroid hormone receptor binding | 1.26% (2/159) | 4.55 | 0.003282 | 0.01631 |
GO:0031644 | regulation of nervous system process | 1.26% (2/159) | 4.55 | 0.003282 | 0.01631 |
GO:2000197 | regulation of ribonucleoprotein complex localization | 1.26% (2/159) | 4.55 | 0.003282 | 0.01631 |
GO:0006275 | regulation of DNA replication | 2.52% (4/159) | 2.72 | 0.003292 | 0.016336 |
GO:0018209 | peptidyl-serine modification | 3.14% (5/159) | 2.34 | 0.003261 | 0.016348 |
GO:0030447 | filamentous growth | 1.89% (3/159) | 3.34 | 0.003335 | 0.016477 |
GO:0071219 | cellular response to molecule of bacterial origin | 1.89% (3/159) | 3.34 | 0.003335 | 0.016477 |
GO:0016192 | vesicle-mediated transport | 6.92% (11/159) | 1.4 | 0.003333 | 0.016516 |
GO:1903320 | regulation of protein modification by small protein conjugation or removal | 3.14% (5/159) | 2.33 | 0.003377 | 0.016662 |
GO:0071704 | organic substance metabolic process | 47.8% (76/159) | 0.37 | 0.00342 | 0.016848 |
GO:0045321 | leukocyte activation | 2.52% (4/159) | 2.7 | 0.003453 | 0.016986 |
GO:0010906 | regulation of glucose metabolic process | 1.89% (3/159) | 3.32 | 0.003465 | 0.017025 |
GO:1903664 | regulation of asexual reproduction | 1.26% (2/159) | 4.48 | 0.003601 | 0.017416 |
GO:0001570 | vasculogenesis | 1.26% (2/159) | 4.48 | 0.003601 | 0.017416 |
GO:0005880 | nuclear microtubule | 1.26% (2/159) | 4.48 | 0.003601 | 0.017416 |
GO:0006337 | nucleosome disassembly | 1.26% (2/159) | 4.48 | 0.003601 | 0.017416 |
GO:0010676 | positive regulation of cellular carbohydrate metabolic process | 1.26% (2/159) | 4.48 | 0.003601 | 0.017416 |
GO:0000124 | SAGA complex | 1.26% (2/159) | 4.48 | 0.003601 | 0.017416 |
GO:0007606 | sensory perception of chemical stimulus | 1.26% (2/159) | 4.48 | 0.003601 | 0.017416 |
GO:0042402 | cellular biogenic amine catabolic process | 1.26% (2/159) | 4.48 | 0.003601 | 0.017416 |
GO:0005721 | pericentric heterochromatin | 1.26% (2/159) | 4.48 | 0.003601 | 0.017416 |
GO:0019220 | regulation of phosphate metabolic process | 5.66% (9/159) | 1.57 | 0.003613 | 0.017454 |
GO:0006346 | DNA methylation-dependent heterochromatin formation | 1.89% (3/159) | 3.3 | 0.003599 | 0.017632 |
GO:0002039 | p53 binding | 1.89% (3/159) | 3.3 | 0.003599 | 0.017632 |
GO:0000018 | regulation of DNA recombination | 2.52% (4/159) | 2.67 | 0.003703 | 0.017838 |
GO:0034708 | methyltransferase complex | 2.52% (4/159) | 2.67 | 0.003703 | 0.017838 |
GO:0000329 | fungal-type vacuole membrane | 1.89% (3/159) | 3.28 | 0.003736 | 0.01797 |
GO:2000018 | regulation of male gonad development | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:2000020 | positive regulation of male gonad development | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0042565 | RNA nuclear export complex | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0061716 | miRNA export from nucleus | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:2001008 | positive regulation of cellulose biosynthetic process | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:2001011 | positive regulation of plant-type cell wall cellulose biosynthetic process | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0042065 | glial cell growth | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0090694 | Scc2-Scc4 cohesin loading complex | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0015607 | ABC-type fatty-acyl-CoA transporter activity | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0015916 | fatty-acyl-CoA transport | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0030325 | adrenal gland development | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0031643 | positive regulation of myelination | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0036269 | swimming behavior | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:1901337 | thioester transport | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0051456 | attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0061774 | cohesin unloading | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0061781 | mitotic cohesin unloading | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0090695 | Wpl/Pds5 cohesin loading/unloading complex | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0030893 | meiotic cohesin complex | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0000747 | conjugation with cellular fusion | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0031383 | regulation of mating projection assembly | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:0031384 | regulation of initiation of mating projection growth | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:2000203 | regulation of ribosomal large subunit export from nucleus | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:2000238 | regulation of tRNA export from nucleus | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:1900147 | regulation of Schwann cell migration | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:1900149 | positive regulation of Schwann cell migration | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:1903977 | positive regulation of glial cell migration | 0.63% (1/159) | 7.94 | 0.004068 | 0.018531 |
GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 1.89% (3/159) | 3.26 | 0.003876 | 0.018565 |
GO:2000059 | negative regulation of ubiquitin-dependent protein catabolic process | 1.89% (3/159) | 3.26 | 0.003876 | 0.018565 |
GO:0003727 | single-stranded RNA binding | 3.14% (5/159) | 2.28 | 0.003869 | 0.018586 |
GO:0010243 | response to organonitrogen compound | 9.43% (15/159) | 1.12 | 0.003905 | 0.018681 |
GO:0008168 | methyltransferase activity | 4.4% (7/159) | 1.82 | 0.003934 | 0.018688 |
GO:0071459 | protein localization to chromosome, centromeric region | 1.26% (2/159) | 4.42 | 0.003933 | 0.018709 |
GO:0045648 | positive regulation of erythrocyte differentiation | 1.26% (2/159) | 4.42 | 0.003933 | 0.018709 |
GO:0001223 | transcription coactivator binding | 1.26% (2/159) | 4.42 | 0.003933 | 0.018709 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 1.26% (2/159) | 4.42 | 0.003933 | 0.018709 |
GO:0010044 | response to aluminum ion | 1.89% (3/159) | 3.22 | 0.004165 | 0.01895 |
GO:0051174 | regulation of phosphorus metabolic process | 5.66% (9/159) | 1.55 | 0.004008 | 0.019011 |
GO:0006446 | regulation of translational initiation | 1.89% (3/159) | 3.24 | 0.004019 | 0.019013 |
GO:0032878 | regulation of establishment or maintenance of cell polarity | 1.89% (3/159) | 3.24 | 0.004019 | 0.019013 |
GO:0008380 | RNA splicing | 3.77% (6/159) | 2.01 | 0.004035 | 0.019063 |
GO:0034250 | positive regulation of cellular amide metabolic process | 3.14% (5/159) | 2.25 | 0.004202 | 0.019093 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 1.26% (2/159) | 4.36 | 0.004279 | 0.019366 |
GO:0007517 | muscle organ development | 1.26% (2/159) | 4.36 | 0.004279 | 0.019366 |
GO:0032890 | regulation of organic acid transport | 1.26% (2/159) | 4.36 | 0.004279 | 0.019366 |
GO:0036293 | response to decreased oxygen levels | 5.03% (8/159) | 1.65 | 0.004298 | 0.019426 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 3.77% (6/159) | 1.99 | 0.004307 | 0.019442 |
GO:0140296 | general transcription initiation factor binding | 1.89% (3/159) | 3.2 | 0.004315 | 0.019451 |
GO:0035295 | tube development | 2.52% (4/159) | 2.6 | 0.004432 | 0.019951 |
GO:0048609 | multicellular organismal reproductive process | 6.92% (11/159) | 1.34 | 0.004492 | 0.020195 |
GO:0005935 | cellular bud neck | 1.26% (2/159) | 4.3 | 0.004639 | 0.020456 |
GO:0045836 | positive regulation of meiotic nuclear division | 1.26% (2/159) | 4.3 | 0.004639 | 0.020456 |
GO:0036310 | ATP-dependent DNA/DNA annealing activity | 1.26% (2/159) | 4.3 | 0.004639 | 0.020456 |
GO:0045913 | positive regulation of carbohydrate metabolic process | 1.26% (2/159) | 4.3 | 0.004639 | 0.020456 |
GO:0070914 | UV-damage excision repair | 1.26% (2/159) | 4.3 | 0.004639 | 0.020456 |
GO:0008494 | translation activator activity | 1.26% (2/159) | 4.3 | 0.004639 | 0.020456 |
GO:0006369 | termination of RNA polymerase II transcription | 1.26% (2/159) | 4.3 | 0.004639 | 0.020456 |
GO:0003968 | RNA-directed 5'-3' RNA polymerase activity | 1.26% (2/159) | 4.3 | 0.004639 | 0.020456 |
GO:0003007 | heart morphogenesis | 1.26% (2/159) | 4.3 | 0.004639 | 0.020456 |
GO:0032454 | histone H3-methyl-lysine-9 demethylase activity | 1.26% (2/159) | 4.3 | 0.004639 | 0.020456 |
GO:0035145 | exon-exon junction complex | 1.26% (2/159) | 4.3 | 0.004639 | 0.020456 |
GO:0045880 | positive regulation of smoothened signaling pathway | 1.26% (2/159) | 4.3 | 0.004639 | 0.020456 |
GO:0001775 | cell activation | 2.52% (4/159) | 2.58 | 0.004628 | 0.020726 |
GO:0070534 | protein K63-linked ubiquitination | 1.89% (3/159) | 3.17 | 0.004624 | 0.020734 |
GO:0001510 | RNA methylation | 1.89% (3/159) | 3.17 | 0.004624 | 0.020734 |
GO:0050890 | cognition | 2.52% (4/159) | 2.58 | 0.004728 | 0.020823 |
GO:0016741 | transferase activity, transferring one-carbon groups | 4.4% (7/159) | 1.77 | 0.004784 | 0.021013 |
GO:0051646 | mitochondrion localization | 1.89% (3/159) | 3.15 | 0.004783 | 0.021037 |
GO:0006950 | response to stress | 37.74% (60/159) | 0.43 | 0.004823 | 0.02116 |
GO:0032993 | protein-DNA complex | 2.52% (4/159) | 2.56 | 0.004933 | 0.021614 |
GO:0010675 | regulation of cellular carbohydrate metabolic process | 3.77% (6/159) | 1.95 | 0.004954 | 0.021678 |
GO:0035556 | intracellular signal transduction | 7.55% (12/159) | 1.25 | 0.004996 | 0.021837 |
GO:0031453 | positive regulation of heterochromatin formation | 1.26% (2/159) | 4.24 | 0.005012 | 0.02185 |
GO:0120263 | positive regulation of heterochromatin organization | 1.26% (2/159) | 4.24 | 0.005012 | 0.02185 |
GO:1903051 | negative regulation of proteolysis involved in protein catabolic process | 1.89% (3/159) | 3.1 | 0.00528 | 0.02299 |
GO:0007275 | multicellular organism development | 12.58% (20/159) | 0.9 | 0.005334 | 0.023195 |
GO:0016055 | Wnt signaling pathway | 1.26% (2/159) | 4.19 | 0.005399 | 0.023299 |
GO:1905114 | cell surface receptor signaling pathway involved in cell-cell signaling | 1.26% (2/159) | 4.19 | 0.005399 | 0.023299 |
GO:1901224 | positive regulation of NIK/NF-kappaB signaling | 1.26% (2/159) | 4.19 | 0.005399 | 0.023299 |
GO:0048699 | generation of neurons | 1.26% (2/159) | 4.19 | 0.005399 | 0.023299 |
GO:0042048 | olfactory behavior | 1.26% (2/159) | 4.19 | 0.005399 | 0.023299 |
GO:0080182 | histone H3-K4 trimethylation | 1.26% (2/159) | 4.19 | 0.005399 | 0.023299 |
GO:0050779 | RNA destabilization | 1.89% (3/159) | 3.08 | 0.005453 | 0.023415 |
GO:0061157 | mRNA destabilization | 1.89% (3/159) | 3.08 | 0.005453 | 0.023415 |
GO:0035196 | miRNA processing | 1.89% (3/159) | 3.08 | 0.005453 | 0.023415 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 1.89% (3/159) | 3.08 | 0.005453 | 0.023415 |
GO:0016592 | mediator complex | 1.89% (3/159) | 3.07 | 0.005628 | 0.02414 |
GO:0044297 | cell body | 3.14% (5/159) | 2.15 | 0.005655 | 0.024222 |
GO:0000976 | transcription cis-regulatory region binding | 10.06% (16/159) | 1.02 | 0.005695 | 0.024303 |
GO:0071705 | nitrogen compound transport | 10.06% (16/159) | 1.02 | 0.005695 | 0.024303 |
GO:0009628 | response to abiotic stimulus | 27.67% (44/159) | 0.53 | 0.005688 | 0.024334 |
GO:0060284 | regulation of cell development | 3.14% (5/159) | 2.14 | 0.00574 | 0.024464 |
GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.89% (3/159) | 3.05 | 0.005808 | 0.024542 |
GO:0016514 | SWI/SNF complex | 1.26% (2/159) | 4.13 | 0.005798 | 0.024563 |
GO:0001217 | DNA-binding transcription repressor activity | 1.26% (2/159) | 4.13 | 0.005798 | 0.024563 |
GO:0051177 | meiotic sister chromatid cohesion | 1.26% (2/159) | 4.13 | 0.005798 | 0.024563 |
GO:0007129 | homologous chromosome pairing at meiosis | 1.26% (2/159) | 4.13 | 0.005798 | 0.024563 |
GO:0071339 | MLL1 complex | 1.26% (2/159) | 4.13 | 0.005798 | 0.024563 |
GO:0071417 | cellular response to organonitrogen compound | 3.77% (6/159) | 1.9 | 0.005807 | 0.024568 |
GO:0001067 | transcription regulatory region nucleic acid binding | 10.06% (16/159) | 1.02 | 0.005889 | 0.024856 |
GO:0070482 | response to oxygen levels | 5.03% (8/159) | 1.57 | 0.005912 | 0.024922 |
GO:0016239 | positive regulation of macroautophagy | 1.26% (2/159) | 4.08 | 0.006211 | 0.025961 |
GO:0048308 | organelle inheritance | 1.26% (2/159) | 4.08 | 0.006211 | 0.025961 |
GO:1902555 | endoribonuclease complex | 1.26% (2/159) | 4.08 | 0.006211 | 0.025961 |
GO:0010369 | chromocenter | 1.26% (2/159) | 4.08 | 0.006211 | 0.025961 |
GO:0005882 | intermediate filament | 1.26% (2/159) | 4.08 | 0.006211 | 0.025961 |
GO:1990823 | response to leukemia inhibitory factor | 1.89% (3/159) | 3.02 | 0.006176 | 0.025972 |
GO:1990830 | cellular response to leukemia inhibitory factor | 1.89% (3/159) | 3.02 | 0.006176 | 0.025972 |
GO:0043069 | negative regulation of programmed cell death | 4.4% (7/159) | 1.69 | 0.006498 | 0.027125 |
GO:0009886 | post-embryonic animal morphogenesis | 1.89% (3/159) | 2.99 | 0.006558 | 0.027279 |
GO:0044815 | DNA packaging complex | 1.89% (3/159) | 2.99 | 0.006558 | 0.027279 |
GO:0051570 | regulation of histone H3-K9 methylation | 1.89% (3/159) | 2.99 | 0.006558 | 0.027279 |
GO:0140747 | regulation of ncRNA transcription | 1.26% (2/159) | 4.03 | 0.006637 | 0.027376 |
GO:0048863 | stem cell differentiation | 1.26% (2/159) | 4.03 | 0.006637 | 0.027376 |
GO:1905348 | endonuclease complex | 1.26% (2/159) | 4.03 | 0.006637 | 0.027376 |
GO:0010520 | regulation of reciprocal meiotic recombination | 1.26% (2/159) | 4.03 | 0.006637 | 0.027376 |
GO:0120162 | positive regulation of cold-induced thermogenesis | 1.26% (2/159) | 4.03 | 0.006637 | 0.027376 |
GO:0009310 | amine catabolic process | 1.26% (2/159) | 4.03 | 0.006637 | 0.027376 |
GO:0046332 | SMAD binding | 1.26% (2/159) | 4.03 | 0.006637 | 0.027376 |
GO:0042826 | histone deacetylase binding | 1.89% (3/159) | 2.97 | 0.006755 | 0.027827 |
GO:0010965 | regulation of mitotic sister chromatid separation | 1.89% (3/159) | 2.96 | 0.006954 | 0.028581 |
GO:0044728 | DNA methylation or demethylation | 1.89% (3/159) | 2.96 | 0.006954 | 0.028581 |
GO:0045948 | positive regulation of translational initiation | 1.26% (2/159) | 3.99 | 0.007076 | 0.028876 |
GO:1990928 | response to amino acid starvation | 1.26% (2/159) | 3.99 | 0.007076 | 0.028876 |
GO:0007635 | chemosensory behavior | 1.26% (2/159) | 3.99 | 0.007076 | 0.028876 |
GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 1.26% (2/159) | 3.99 | 0.007076 | 0.028876 |
GO:0007476 | imaginal disc-derived wing morphogenesis | 1.26% (2/159) | 3.99 | 0.007076 | 0.028876 |
GO:1990837 | sequence-specific double-stranded DNA binding | 10.06% (16/159) | 0.99 | 0.007041 | 0.028904 |
GO:0006364 | rRNA processing | 3.77% (6/159) | 1.83 | 0.00724 | 0.029507 |
GO:0048511 | rhythmic process | 5.03% (8/159) | 1.52 | 0.007322 | 0.029772 |
GO:0050767 | regulation of neurogenesis | 2.52% (4/159) | 2.39 | 0.007316 | 0.029782 |
GO:0043934 | sporulation | 3.14% (5/159) | 2.05 | 0.007533 | 0.030413 |
GO:0018027 | peptidyl-lysine dimethylation | 1.26% (2/159) | 3.94 | 0.007528 | 0.03043 |
GO:1905269 | positive regulation of chromatin organization | 1.26% (2/159) | 3.94 | 0.007528 | 0.03043 |
GO:0007631 | feeding behavior | 1.26% (2/159) | 3.94 | 0.007528 | 0.03043 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 1.26% (2/159) | 3.94 | 0.007528 | 0.03043 |
GO:0035114 | imaginal disc-derived appendage morphogenesis | 1.26% (2/159) | 3.94 | 0.007528 | 0.03043 |
GO:0035065 | regulation of histone acetylation | 1.89% (3/159) | 2.91 | 0.007575 | 0.030511 |
GO:0048571 | long-day photoperiodism | 1.89% (3/159) | 2.91 | 0.007575 | 0.030511 |
GO:0019898 | extrinsic component of membrane | 3.14% (5/159) | 2.04 | 0.007637 | 0.030725 |
GO:0010941 | regulation of cell death | 7.55% (12/159) | 1.17 | 0.00773 | 0.031026 |
GO:0010498 | proteasomal protein catabolic process | 4.4% (7/159) | 1.64 | 0.007725 | 0.031043 |
GO:1902038 | positive regulation of hematopoietic stem cell differentiation | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:1905610 | regulation of mRNA cap binding | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:1905612 | positive regulation of mRNA cap binding | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0001832 | blastocyst growth | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0005726 | perichromatin fibrils | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0007403 | glial cell fate determination | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0035886 | vascular associated smooth muscle cell differentiation | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0035887 | aortic smooth muscle cell differentiation | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0043974 | histone H3-K27 acetylation | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0060318 | definitive erythrocyte differentiation | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0060343 | trabecula formation | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0060347 | heart trabecula formation | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0061626 | pharyngeal arch artery morphogenesis | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0070307 | lens fiber cell development | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:1902895 | positive regulation of miRNA transcription | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0046726 | positive regulation by virus of viral protein levels in host cell | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0006363 | termination of RNA polymerase I transcription | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:1900050 | negative regulation of histone exchange | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0071169 | establishment of protein localization to chromatin | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0015910 | long-chain fatty acid import into peroxisome | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0032044 | DSIF complex | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0016601 | Rac protein signal transduction | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0031934 | mating-type region heterochromatin | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0034087 | establishment of mitotic sister chromatid cohesion | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0097355 | protein localization to heterochromatin | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:1902682 | protein localization to pericentric heterochromatin | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0061775 | cohesin loading activity | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0062022 | mitotic cohesin ssDNA (lagging strand) loading | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0032443 | regulation of ergosterol biosynthetic process | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0010789 | meiotic sister chromatid cohesion involved in meiosis I | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0110092 | nucleus leading edge | 0.63% (1/159) | 6.94 | 0.008119 | 0.031173 |
GO:0032535 | regulation of cellular component size | 3.14% (5/159) | 2.03 | 0.007848 | 0.031464 |
GO:0009756 | carbohydrate mediated signaling | 2.52% (4/159) | 2.34 | 0.008302 | 0.031803 |
GO:0010182 | sugar mediated signaling pathway | 2.52% (4/159) | 2.34 | 0.008302 | 0.031803 |
GO:0060765 | regulation of androgen receptor signaling pathway | 1.26% (2/159) | 3.9 | 0.007993 | 0.031822 |
GO:0008097 | 5S rRNA binding | 1.26% (2/159) | 3.9 | 0.007993 | 0.031822 |
GO:0035613 | RNA stem-loop binding | 1.26% (2/159) | 3.9 | 0.007993 | 0.031822 |
GO:1990825 | sequence-specific mRNA binding | 1.26% (2/159) | 3.9 | 0.007993 | 0.031822 |
GO:0070887 | cellular response to chemical stimulus | 13.21% (21/159) | 0.81 | 0.008323 | 0.031849 |
GO:0010927 | cellular component assembly involved in morphogenesis | 3.14% (5/159) | 2.03 | 0.007955 | 0.031856 |
GO:0040008 | regulation of growth | 9.43% (15/159) | 1.01 | 0.007988 | 0.03195 |
GO:0032986 | protein-DNA complex disassembly | 1.26% (2/159) | 3.85 | 0.00847 | 0.032267 |
GO:0043001 | Golgi to plasma membrane protein transport | 1.26% (2/159) | 3.85 | 0.00847 | 0.032267 |
GO:0035120 | post-embryonic appendage morphogenesis | 1.26% (2/159) | 3.85 | 0.00847 | 0.032267 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 1.89% (3/159) | 2.85 | 0.008451 | 0.032302 |
GO:0071824 | protein-DNA complex subunit organization | 2.52% (4/159) | 2.33 | 0.008599 | 0.032722 |
GO:0070936 | protein K48-linked ubiquitination | 1.89% (3/159) | 2.84 | 0.008679 | 0.032991 |
GO:0030427 | site of polarized growth | 3.14% (5/159) | 2.0 | 0.008732 | 0.033157 |
GO:0070972 | protein localization to endoplasmic reticulum | 1.26% (2/159) | 3.81 | 0.008959 | 0.033981 |
GO:0030111 | regulation of Wnt signaling pathway | 2.52% (4/159) | 2.3 | 0.009057 | 0.034315 |
GO:0042325 | regulation of phosphorylation | 4.4% (7/159) | 1.59 | 0.009198 | 0.034809 |
GO:0051050 | positive regulation of transport | 4.4% (7/159) | 1.59 | 0.00928 | 0.035084 |
GO:0005681 | spliceosomal complex | 3.14% (5/159) | 1.97 | 0.009319 | 0.035152 |
GO:0046982 | protein heterodimerization activity | 3.14% (5/159) | 1.97 | 0.009319 | 0.035152 |
GO:0045807 | positive regulation of endocytosis | 1.89% (3/159) | 2.8 | 0.009384 | 0.035283 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 1.89% (3/159) | 2.8 | 0.009384 | 0.035283 |
GO:0034504 | protein localization to nucleus | 2.52% (4/159) | 2.29 | 0.009371 | 0.035311 |
GO:1900036 | positive regulation of cellular response to heat | 1.26% (2/159) | 3.77 | 0.009461 | 0.035378 |
GO:0048311 | mitochondrion distribution | 1.26% (2/159) | 3.77 | 0.009461 | 0.035378 |
GO:0120161 | regulation of cold-induced thermogenesis | 1.26% (2/159) | 3.77 | 0.009461 | 0.035378 |
GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 1.26% (2/159) | 3.77 | 0.009461 | 0.035378 |
GO:0042800 | histone methyltransferase activity (H3-K4 specific) | 1.26% (2/159) | 3.77 | 0.009461 | 0.035378 |
GO:0098852 | lytic vacuole membrane | 2.52% (4/159) | 2.28 | 0.009531 | 0.035601 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2.52% (4/159) | 2.28 | 0.009692 | 0.036126 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 3.14% (5/159) | 1.96 | 0.009684 | 0.036132 |
GO:0008092 | cytoskeletal protein binding | 5.03% (8/159) | 1.45 | 0.009705 | 0.036134 |
GO:0008360 | regulation of cell shape | 1.89% (3/159) | 2.77 | 0.009872 | 0.036718 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.26% (2/159) | 3.73 | 0.009975 | 0.036821 |
GO:0072089 | stem cell proliferation | 1.26% (2/159) | 3.73 | 0.009975 | 0.036821 |
GO:0030900 | forebrain development | 1.26% (2/159) | 3.73 | 0.009975 | 0.036821 |
GO:0001843 | neural tube closure | 1.26% (2/159) | 3.73 | 0.009975 | 0.036821 |
GO:0045747 | positive regulation of Notch signaling pathway | 1.26% (2/159) | 3.73 | 0.009975 | 0.036821 |
GO:0060606 | tube closure | 1.26% (2/159) | 3.73 | 0.009975 | 0.036821 |
GO:0044665 | MLL1/2 complex | 1.26% (2/159) | 3.73 | 0.009975 | 0.036821 |
GO:0048580 | regulation of post-embryonic development | 8.81% (14/159) | 1.01 | 0.009989 | 0.036832 |
GO:0009059 | macromolecule biosynthetic process | 8.18% (13/159) | 1.06 | 0.010149 | 0.037381 |
GO:0016579 | protein deubiquitination | 1.89% (3/159) | 2.75 | 0.010375 | 0.038176 |
GO:0043014 | alpha-tubulin binding | 1.26% (2/159) | 3.69 | 0.010501 | 0.038475 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 1.26% (2/159) | 3.69 | 0.010501 | 0.038475 |
GO:0018023 | peptidyl-lysine trimethylation | 1.26% (2/159) | 3.69 | 0.010501 | 0.038475 |
GO:0072594 | establishment of protein localization to organelle | 3.77% (6/159) | 1.71 | 0.010523 | 0.038514 |
GO:0008270 | zinc ion binding | 5.03% (8/159) | 1.43 | 0.010481 | 0.038525 |
GO:0007049 | cell cycle | 4.4% (7/159) | 1.55 | 0.01059 | 0.038717 |
GO:0006304 | DNA modification | 1.89% (3/159) | 2.73 | 0.010632 | 0.03879 |
GO:2001252 | positive regulation of chromosome organization | 1.89% (3/159) | 2.73 | 0.010632 | 0.03879 |
GO:0031396 | regulation of protein ubiquitination | 2.52% (4/159) | 2.23 | 0.010698 | 0.03899 |
GO:0022411 | cellular component disassembly | 3.14% (5/159) | 1.92 | 0.010836 | 0.039451 |
GO:0097659 | nucleic acid-templated transcription | 2.52% (4/159) | 2.23 | 0.010872 | 0.03954 |
GO:0002244 | hematopoietic progenitor cell differentiation | 1.26% (2/159) | 3.66 | 0.01104 | 0.039938 |
GO:1901222 | regulation of NIK/NF-kappaB signaling | 1.26% (2/159) | 3.66 | 0.01104 | 0.039938 |
GO:0004402 | histone acetyltransferase activity | 1.26% (2/159) | 3.66 | 0.01104 | 0.039938 |
GO:1902562 | H4 histone acetyltransferase complex | 1.26% (2/159) | 3.66 | 0.01104 | 0.039938 |
GO:0045184 | establishment of protein localization | 6.92% (11/159) | 1.16 | 0.011001 | 0.039965 |
GO:1901983 | regulation of protein acetylation | 1.89% (3/159) | 2.71 | 0.011157 | 0.040278 |
GO:2001242 | regulation of intrinsic apoptotic signaling pathway | 1.89% (3/159) | 2.71 | 0.011157 | 0.040278 |
GO:0048546 | digestive tract morphogenesis | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:1905618 | obsolete positive regulation of miRNA-mediated gene silencing by inhibition of translation | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0003151 | outflow tract morphogenesis | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0043696 | dedifferentiation | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0043697 | cell dedifferentiation | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0051145 | smooth muscle cell differentiation | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:2000630 | positive regulation of miRNA metabolic process | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0106349 | snRNA methylation | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:1990437 | snRNA 2'-O-methylation | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:1990438 | U6 2'-O-snRNA methylation | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0004803 | transposase activity | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0004984 | olfactory receptor activity | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0006313 | transposition, DNA-mediated | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0018143 | nucleic acid-protein covalent cross-linking | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0018144 | RNA-protein covalent cross-linking | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0019029 | helical viral capsid | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0039525 | modulation by virus of host chromatin organization | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0039618 | T=pseudo3 icosahedral viral capsid | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0039707 | pore formation by virus in membrane of host cell | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0044161 | host cell cytoplasmic vesicle | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0044162 | host cell cytoplasmic vesicle membrane | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0044385 | integral to membrane of host cell | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0044658 | pore formation in membrane of host by symbiont | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0047507 | (deoxy)nucleoside-phosphate kinase activity | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0050911 | detection of chemical stimulus involved in sensory perception of smell | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0052767 | mannosyl-oligosaccharide 1,6-alpha-mannosidase activity | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0075512 | clathrin-dependent endocytosis of virus by host cell | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0098006 | viral DNA genome packaging, headful | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:1903818 | positive regulation of voltage-gated potassium channel activity | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0034508 | centromere complex assembly | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:1903097 | obsolete regulation of CENP-A containing nucleosome assembly | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0003382 | epithelial cell morphogenesis | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0044848 | biological phase | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0046293 | formaldehyde biosynthetic process | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:1990636 | reproductive senescence | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0045131 | pre-mRNA branch point binding | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0036033 | mediator complex binding | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0070058 | tRNA gene clustering | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0070550 | rDNA chromatin condensation | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:1905524 | negative regulation of protein autoubiquitination | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:2000200 | regulation of ribosomal subunit export from nucleus | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0002520 | immune system development | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:1902185 | positive regulation of shoot apical meristem development | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0030895 | apolipoprotein B mRNA editing enzyme complex | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0030846 | termination of RNA polymerase II transcription, poly(A)-coupled | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0034693 | U11/U12 snRNP | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0003181 | atrioventricular valve morphogenesis | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0003187 | ventriculo bulbo valve morphogenesis | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:0004438 | phosphatidylinositol-3-phosphatase activity | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:1903975 | regulation of glial cell migration | 0.63% (1/159) | 6.36 | 0.012154 | 0.04056 |
GO:1901698 | response to nitrogen compound | 9.43% (15/159) | 0.95 | 0.01131 | 0.040788 |
GO:1905818 | regulation of chromosome separation | 1.89% (3/159) | 2.66 | 0.012251 | 0.040845 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:0033046 | negative regulation of sister chromatid segregation | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:0007530 | sex determination | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:0004520 | endodeoxyribonuclease activity | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:0007417 | central nervous system development | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:1902183 | regulation of shoot apical meristem development | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:0061733 | peptide-lysine-N-acetyltransferase activity | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:0034720 | histone H3-K4 demethylation | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:0019953 | sexual reproduction | 1.26% (2/159) | 3.62 | 0.01159 | 0.041066 |
GO:0016072 | rRNA metabolic process | 3.77% (6/159) | 1.69 | 0.011401 | 0.041074 |
GO:0010508 | positive regulation of autophagy | 1.89% (3/159) | 2.69 | 0.011425 | 0.041116 |
GO:0051094 | positive regulation of developmental process | 7.55% (12/159) | 1.09 | 0.011645 | 0.041217 |
GO:0000793 | condensed chromosome | 1.89% (3/159) | 2.68 | 0.011697 | 0.041317 |
GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 1.89% (3/159) | 2.68 | 0.011697 | 0.041317 |
GO:1901001 | negative regulation of response to salt stress | 1.89% (3/159) | 2.64 | 0.012534 | 0.041707 |
GO:0031398 | positive regulation of protein ubiquitination | 1.89% (3/159) | 2.64 | 0.012534 | 0.041707 |
GO:0000902 | cell morphogenesis | 8.18% (13/159) | 1.02 | 0.012668 | 0.042113 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 1.26% (2/159) | 3.55 | 0.012726 | 0.042183 |
GO:1905819 | negative regulation of chromosome separation | 1.26% (2/159) | 3.55 | 0.012726 | 0.042183 |
GO:1901797 | negative regulation of signal transduction by p53 class mediator | 1.26% (2/159) | 3.55 | 0.012726 | 0.042183 |
GO:0035306 | positive regulation of dephosphorylation | 1.26% (2/159) | 3.58 | 0.012152 | 0.042662 |
GO:0034451 | centriolar satellite | 1.26% (2/159) | 3.58 | 0.012152 | 0.042662 |
GO:1901798 | positive regulation of signal transduction by p53 class mediator | 1.26% (2/159) | 3.58 | 0.012152 | 0.042662 |
GO:0005815 | microtubule organizing center | 3.77% (6/159) | 1.67 | 0.012093 | 0.042673 |
GO:0003697 | single-stranded DNA binding | 2.52% (4/159) | 2.18 | 0.012142 | 0.042757 |
GO:0008234 | cysteine-type peptidase activity | 2.52% (4/159) | 2.18 | 0.012142 | 0.042757 |
GO:1901699 | cellular response to nitrogen compound | 3.77% (6/159) | 1.64 | 0.013186 | 0.043665 |
GO:0045839 | negative regulation of mitotic nuclear division | 1.26% (2/159) | 3.52 | 0.013311 | 0.043997 |
GO:0034046 | poly(G) binding | 1.26% (2/159) | 3.52 | 0.013311 | 0.043997 |
GO:0044087 | regulation of cellular component biogenesis | 5.03% (8/159) | 1.36 | 0.013373 | 0.044157 |
GO:1902806 | regulation of cell cycle G1/S phase transition | 1.89% (3/159) | 2.6 | 0.013702 | 0.045202 |
GO:1901532 | regulation of hematopoietic progenitor cell differentiation | 1.26% (2/159) | 3.48 | 0.013908 | 0.045707 |
GO:0010822 | positive regulation of mitochondrion organization | 1.26% (2/159) | 3.48 | 0.013908 | 0.045707 |
GO:0005643 | nuclear pore | 1.26% (2/159) | 3.48 | 0.013908 | 0.045707 |
GO:0071222 | cellular response to lipopolysaccharide | 1.26% (2/159) | 3.48 | 0.013908 | 0.045707 |
GO:0060429 | epithelium development | 1.89% (3/159) | 2.58 | 0.014004 | 0.045889 |
GO:0003730 | mRNA 3'-UTR binding | 1.89% (3/159) | 2.58 | 0.014004 | 0.045889 |
GO:0045860 | positive regulation of protein kinase activity | 1.89% (3/159) | 2.58 | 0.014004 | 0.045889 |
GO:0140694 | non-membrane-bounded organelle assembly | 3.14% (5/159) | 1.82 | 0.014042 | 0.04597 |
GO:0004197 | cysteine-type endopeptidase activity | 1.89% (3/159) | 2.57 | 0.014309 | 0.0468 |
GO:0051985 | negative regulation of chromosome segregation | 1.26% (2/159) | 3.45 | 0.014517 | 0.047211 |
GO:0048497 | maintenance of floral organ identity | 1.26% (2/159) | 3.45 | 0.014517 | 0.047211 |
GO:0090700 | maintenance of plant organ identity | 1.26% (2/159) | 3.45 | 0.014517 | 0.047211 |
GO:0043425 | bHLH transcription factor binding | 1.26% (2/159) | 3.45 | 0.014517 | 0.047211 |
GO:0050994 | regulation of lipid catabolic process | 1.26% (2/159) | 3.45 | 0.014517 | 0.047211 |
GO:0071480 | cellular response to gamma radiation | 1.26% (2/159) | 3.45 | 0.014517 | 0.047211 |
GO:0030182 | neuron differentiation | 1.89% (3/159) | 2.56 | 0.014618 | 0.04745 |
GO:2001234 | negative regulation of apoptotic signaling pathway | 1.89% (3/159) | 2.56 | 0.014618 | 0.04745 |
GO:0003002 | regionalization | 5.66% (9/159) | 1.24 | 0.014661 | 0.047546 |
GO:0043393 | regulation of protein binding | 1.89% (3/159) | 2.55 | 0.014931 | 0.048374 |
GO:0071407 | cellular response to organic cyclic compound | 3.14% (5/159) | 1.8 | 0.015016 | 0.048604 |
GO:0001400 | mating projection base | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0007116 | regulation of cell budding | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:1901900 | regulation of protein localization to cell division site | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:1901901 | regulation of protein localization to cell division site involved in cytokinesis | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:1903501 | positive regulation of mitotic actomyosin contractile ring assembly | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:2000433 | positive regulation of cytokinesis, actomyosin contractile ring assembly | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0060903 | positive regulation of meiosis I | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0048730 | epidermis morphogenesis | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0120259 | 7SK snRNP | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0010213 | non-photoreactive DNA repair | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0001178 | regulation of transcriptional start site selection at RNA polymerase II promoter | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0004170 | dUTP diphosphatase activity | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0004314 | [acyl-carrier-protein] S-malonyltransferase activity | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0008362 | chitin-based embryonic cuticle biosynthetic process | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0016063 | rhodopsin biosynthetic process | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0016419 | S-malonyltransferase activity | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0019043 | establishment of viral latency | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0035158 | regulation of tube diameter, open tracheal system | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0039579 | suppression by virus of host ISG15-protein conjugation | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0042302 | structural constituent of cuticle | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0044220 | host cell perinuclear region of cytoplasm | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0044826 | viral genome integration into host DNA | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0046080 | dUTP metabolic process | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0046081 | dUTP catabolic process | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0046154 | rhodopsin metabolic process | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0046798 | viral portal complex | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0052111 | modification by symbiont of host structure | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0075713 | establishment of integrated proviral latency | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:1905499 | trichome papilla formation | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0010742 | macrophage derived foam cell differentiation | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0036268 | swimming | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0061920 | protein propionyltransferase activity | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0061921 | peptidyl-lysine propionylation | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0090077 | foam cell differentiation | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0097677 | STAT family protein binding | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0120300 | peptide lactyltransferase activity | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0120301 | histone lactyltransferase activity | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0140065 | peptide butyryltransferase activity | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0140066 | peptidyl-lysine crotonylation | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0140067 | peptidyl-lysine butyrylation | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0140069 | histone butyryltransferase activity | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0042760 | very long-chain fatty acid catabolic process | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0140588 | chromatin looping | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0000795 | synaptonemal complex | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0008278 | cohesin complex | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0034517 | ribophagy | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0120113 | cytoplasm to vacuole transport by the NVT pathway | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0031045 | dense core granule | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0071233 | cellular response to leucine | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:1903666 | positive regulation of asexual reproduction | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0097100 | supercoiled DNA binding | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0010609 | mRNA localization resulting in post-transcriptional regulation of gene expression | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0030847 | termination of RNA polymerase II transcription, exosome-dependent | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0045501 | regulation of sevenless signaling pathway | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0045874 | positive regulation of sevenless signaling pathway | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0060037 | pharyngeal system development | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0070197 | meiotic attachment of telomere to nuclear envelope | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0070772 | PAS complex | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0061172 | regulation of establishment of bipolar cell polarity | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:1904846 | negative regulation of establishment of bipolar cell polarity | 0.63% (1/159) | 5.94 | 0.016173 | 0.04903 |
GO:0006513 | protein monoubiquitination | 1.89% (3/159) | 2.5 | 0.016219 | 0.049129 |
GO:0030163 | protein catabolic process | 4.4% (7/159) | 1.45 | 0.015204 | 0.049167 |
GO:0006810 | transport | 16.98% (27/159) | 0.61 | 0.016351 | 0.049483 |
GO:0006376 | mRNA splice site selection | 1.26% (2/159) | 3.36 | 0.01641 | 0.049532 |
GO:0043627 | response to estrogen | 1.26% (2/159) | 3.36 | 0.01641 | 0.049532 |
GO:0043392 | negative regulation of DNA binding | 1.26% (2/159) | 3.36 | 0.01641 | 0.049532 |